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In vitro-diagnostiikassa eletään murrosvaihdetta. Sen sijaan että näytteitä lähetettäisiin 
keskuslaboratorioihin analysoitavaksi, pyritään analysointi tekemään yhä enenevissä 
määrin nopeaan vieridiagnostiikkaan perustuvilla laitteilla suoraan lääkärin toimistossa, 
sairaalavuoteen vieressä tai jopa potilaan kotona. Nämä laitteet perustuvat yhä 
enenevissä määrin mikrofluidistiikkaan, jossa pieniä nestemääriä käsitellään 
mikroskaalan nestekanavissa. Mikrofluidistiikan avulla laitteita on voitu miniatyrisoida, 
jolloin niiden vaatimia näyte ja reagenssimääriä on saatu pienennettyä merkittävästi. 
Vierihoitodiagnostiikan osalta määritysten herkkyydet ja havaintorajat eivät kuitenkaan 
ole vielä perinteisten menetelmien tasolla.  
Tämän tutkimuksen tarkoituksena oli selvittää, miten mikrofluidistisen 
määrityskasetin suorituskykyä voitaisiin parantaa erilaisilla menetelmillä. Tavoitteena 
oli tarkastella miten eri polystyreenimateriaalit ja geometriat vaikuttavat 
immunomäärityksen suorituskykyyn.  
Tutkimuksessa käytettiin ruiskuvalettuja mikrofluidistiikkakasetteja, joiden pinnalle 
valmistettiin spesifinen vasta-ainepinta. Analyytin konsentraation havaitsemiseen 
käytettiin europium-kelaatteja sisältäviä, fluoresoivia nanopartikkeleita, joilla on saatu 
aikaan suuria signaalitasoja ja parempia herkkyyksiä perinteisiin leimoihin verrattuna. 
Geometrian osalta immunomäärityksestä luotiin yksinkertaistettu 
elementtimenetelmämalli (FEM, finite element method), jonka avulla geometrian 
vaikutuksia pyrittiin tarkasteleman.  
Tulokset osoittivat, että epäspesifisen sitoutumisen aiheuttamat taustan signaalitasot 
ovat lähes samat materiaalista riippumatta, mutta polystyreenilaatu Empera 124N antaa 
parhaimmat signaalitasot muihin materiaaleihin verrattuna. Alkuperäisten 
reaktiokammioiden FEM-mallit paljastivat määrityksen voimakkaasti 
diffuusiorajoitteiseksi. Tämän pohjalta suunniteltiin pienempi reaktiokammio, jossa 
diffuusiorajoitteisuutta vähennettiin liikuttelemalla näytettä edestakaisin reagoivan 
pinnan yli määrityksen aikana. Tällä tavalla toteutetun määrityksen herkkyys nousi n. 
1.4 kertaisesti ja havaintoraja laski 1mU/L:sta n. 0.52 mU/L:aan. Mikrorakenteiden 
vaikutusta määritykseen kokeiltiin myös ja niiden käyttäminen reaktiokammiossa nosti 
herkkyyttä 3.8 kertaisesti. 
Tulosten perusteella voidaan todeta että jo yksinkertaisellakin FEM-mallilla 
voidaan kuvata systeemin toimintaa ja tehdä optimointeja. Pienemmän reaktiokammion 
ansiosta määrityksen herkkyyttä ja havaintorajaa saatiin parannettua ja samalla 
pienennettiin myös valmistuksessa käytettävien reagenssien määrää. Edestakaisen 
virtauksen kontrollointi ja mittauskohdan määritys vaativat vielä parannuksia.  
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In-vitro diagnostics is currently going through changes. Instead of using central 
laboratories to analyze samples, point-of-care (POC) diagnostic devices are used more 
and more. With these devices tests can be performed rapidly near the patient in a 
doctor’s office, at bedside or at a patient’s home. Most POC devices are based on 
microfluidics, where small fluid volumes are handled inside micro scale channels. With 
microfluidics it has been possible to miniaturize these devices. Thus, their sample and 
reagent consumption is significantly smaller than in conventional methods. What comes 
to the performance of POC devices’, their sensitivities and limit of detection values are 
still worse than in conventional methods. 
The objective of this research was to study how the performance of a microfluidic 
immunoassay cartridge would be enhanced. The aim was to study how different 
polystyrene grades and reaction chamber geometries affect immunoassay performance. 
Injection molded microfluidic cartridges were used in the research. Specific 
antibody coating was fabricated on the reaction chamber surface. Analyte concentration 
was measured with fluorescence nanoparticles containing europium chelates. These 
nanoparticles were used as they provide higher signal levels and better sensitivities than 
conventional fluorescence labels. For studying the effects of geometry, a simplified 
finite element method (FEM) model was created to simulate the immunoreactions 
occurring inside a chamber. 
Results show that signal levels caused by unspecific binding of labels are similar in 
all materials, but with Empera 124N polystyrene grade signal levels of specific binding 
were higher than with other materials. FEM models of original reaction chambers 
showed that the system is fully diffusion limited. New smaller geometries were 
designed with the help of the FEM model. The main difference was that sample was 
moved back and forth over the reaction area during incubation. Measurement sensitivity 
was increased about 1.4-fold and the limit of detection was decreased from 1 mU/L to 
0.52 mU/L. Micro structures on the reacting surface, were also tested and they increased 
measurement sensitivity by 3.8–fold compared to a smooth surface. 
As a conclusion it can be said that already a simple FEM model can be used to 
describe what happens in a system and how the system can be optimized. As a smaller 
reaction chamber was used, sensitivity and the limit of detection were enhanced and 
reagent consumption during fabrication was decreased. There are still some problems 
concerning the control of reciprocating flow and its repeatability which need to be 
solved.  
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ABBREVIATIONS AND NOTATIONS 
Abbreviations 
Ab    Antibody 
Ag    Antigen 
Bio-MAb  Biotinylated monoclonal antibody 
BP    Binding place 
BPD    Binding place density 
BSA    Bovine serum albumin 
CPS    Counts per second 
cTnI    Cardiac troponin I 
ELISA   Enzyme linked immunosorbent assay 
EOF    Electro-osmotic flow 
Eu    Europium 
Fab Antibody binding fragment, part of an antibody which is able to 
bind on antigen 
Fc    Fragment crystallisable part of an antibody 
FIA    Fluorescence immunoassay 
FEM    Finite element method 
HAAA   Human anti-animal antibody 
IgG    Immunogloblin G 
IVD   In vitro diagnostics 
LOD   Limit of detection 
NP    Nanoparticle 
NPS    Nanoparticle bound on the surface 
PDE    Partial differential equation 
PMMA  Poly methyl methacrylate 
POC    Point-of-care 
POCT    Point of care testing 
PS    Polystyrene 
RIA    Radio isotopic assay 
SAv-SH  Thiolated streptavidin 
SBC    Styrene butadiene copolymer 
TSH    Thyroid stimulating hormone, Thyrotropin 
TUT   Tampere University of Technology 
UTU    University of Turku 
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Notations 
ࢇ   Displacement matrix 
ܣ   Area of a channel cross-section 
Bgr    Average of a background signal 
Bgr-ı   Standard deviation of a background signal 
ܿ଴,௜   Initial concentration of a compound i 
ܿ௜   Concentration of a compound i 
ܿ௞   k:th used concentration value 
݀   Diffusion distance 
ܦ௛௬ௗ   Hydraulic diameter of a channel 
ܦ௜   Diffusion coefficient of the compound i 
ܦ௦,௜   Surface diffusion coefficient of the compound i 
ࢌ   Matrix for forces balancing loads and initial strains 
ࡲ   Volume force matrix caused by gravity 
ࢍ   Gravity vector 
ࡵ   Identity matrix 
݇௔   Association rate constant 
݇஻   Boltzmann’s constant, 1.3806488×10
-23 m2 kg s-2 K-1 
݇ௗ   Dissociation rate constant 
ܭ஺   Association constant 
ܭ஽   Dissociation constant 
ࡷ   Stiffness matrix 
ܮ௘௡௧௥   Entrance length  
ܮ௜   Plug length of the fluid i 
࢔   Boundary normal vector 
ܰ   The amount of parallel samples 
ܰܿ   The number of different concentrations used in an immunoassay 
஺ܰ   The Avogadro constant, 6.022×10
23 pcs mol-1 
ࡺ࢏   Flux vector of the compound i 
ࡺ௦,௜   Flux vector for surface specie i 
݌   Pressure 
ο݌௖௔௣   Pressure drop caused by capillary force 
ο݌௖௛௔௡௡௘௟  Pressure difference over channel 
ο݌ௗ௥௔௚   Pressure drop caused by friction 
݌௘௡௧௥   Entrance pressure 
ܲ   Perimeter of a channel cross-section 
ݒ   Average velocity 
࢜   Velocity vector 
ݎ௖௛௔   Radius of a channel 
ݎ௜   Stokes-Einstein radius of the compound i 
࢘   Matrix for applied loads 
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ܴ   Reaction rate 
ܴ଴   Initial reaction rate 
ܴ௛௬ௗ   Hydraulic resistance 
ܴ௜   Reaction rate for the compound i 
ܴ௕,௜  Reaction rate occurring between surface and bulk solution (for 
compound i) 
ܴ௦,௜   Reaction rate occurring between surface species (for compound i) 
ܴ݁   Reynolds number 
ݏҧ௖ೖ   Signal average of used concentration ܿ௞  
ݏ଴௜   Signal value from zero sample number i 
ݐ   Time in seconds  
ܶ   Temperature in kelvins 
଴ܸ   Flow rate at the inlet 
ߛ   Surface tension 
ߛ௅ீ   Surface tension between liquid and gas 
ߛௌீ   Surface tension between solid and gas 
ߛௌ௅   Surface tension between solid and liquid 
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ߠ   Contact angle 
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ߤ௜   Dynamic viscosity of fluid i 
ߩ   Fluid density 
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1 INTRODUCTION 
1.1 ReDia project 
This thesis is a part of Tekes-funded ReDia project which was started on April 2011. 
Main objective of the project is to develop ready-to-use microfluidic cartridges for 
affordable point-of-care diagnostics. The project aims to develop a point-of-care (POC) 
testing cartridge for tuberculosis and cardiac troponin I (cTnI). The project is performed 
in co-operation with Tampere University of Technology (TUT), University of Turku 
(UTU) and University of Delhi. Companies included are DHR Finland/Innotrac 
Diagnostics, Jatec, Kaivogen, Kaptas, Medisize, Medix Biochemica, NanoFoot and 
Span diagnostics Ltd. (India). The department of Automation Science and Engineering 
in TUT acts as a project coordinator and is responsible for microfluidics. The 
department of Production Engineering in TUT focuses on an assembly of cartridges and 
has knowledge on laser welding. Department of Biotechnology in UTU has knowledge 
about nanoparticles and other chemistry on the cartridge. The project is organized into 
three work packages: 
 
1. Production technologies for affordable microfluidic immunoassays 
1. Channel fabrication using injection molding 
2. Channel bonding using laser welding 
3. Material processing using gamma irradiation 
4. Reagent deposition 
5. Product integration 
 
2. Microfluidic tuberculosis assay 
1. Production of capture and detection antibodies 
2. Engineered monoclonal antibody against antigens of mycobactericum 
tuberculosis 
3. Setting up a heterogeneous nanoparticle assay for tuberculosis in a 
microfluidic cartridge 
4. Demonstration of the heterogeneous nanoparticle-based tuberculosis 
assay 
5. Evaluation of the heterogeneous nanoparticle-based tuberculosis assay 
using clinical samples  
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3. Microfluidic cTnI assay 
1. Design of a reaction chamber for heterogeneous cTnI assay 
2. Setting up a heterogeneous cTnI assay in a microfluidic cartridge 
3. Development of microfluidic sample pre-processing methods 
4. Demonstration of the heterogeneous nanoparticle-based cTnI assay 
5. Evaluation of the heterogeneous nanoparticle-based cTnI assay using 
clinical samples 
6. Development of sample introduction methods 
 
This thesis covers mostly part 3.1 where the objective is to improve performance of the 
assay in the cartridge by testing different geometries, cartridge materials and washing 
procedures for the reaction chamber. Instead of cTnI, TSH is used as a model assay. 
1.2 Microfluidic cartridge for immunoassay 
ReDia-project uses a disposable immunoassay cartridge which was first designed in an 
earlier NanoFlow project (Figure 1.1). The cartridge is designed to perform several 
microfluidic tasks to ensure a reliable result from an immunoassay: 
 
1. Sample inlet 
2. Channel for buffer solution 
3. Volume metering 
4. Mixer 
5. Channel containing dried Eu-nanoparticle labels 
6. Reaction chamber containing a dried immunoassay surface 
7. Chamber for washing solution 
8. Waste chamber 
 
 
The operational principle of the cartridge is as follows. First, blood or plasma sample is 
inserted in the cartridge through inlet (1). Pressure difference is used to drive the sample 
plug to the end of the sample channel where certain volume of sample is metered (3). 
Then the sample plug is mixed (4) with buffer solution (2). Mixing will dilute analyte 
and it may cause lower signal levels in fluorescence measurements, but it is needed to 
avoid a hook effect and to decrease a matrix-effect. 
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Figure 1.1. Schematics of the microfluidic immunoassay cartridge at the beginning of 
the ReDia-project. 
 
Next comes the immunoassay part: Sample is driven in to the reaction chamber (6) 
through a channel where Europium nanoparticle labels have been dried (5). 
Nanoparticles diffuse in the sample and begin to bind analyte on their surface. In the 
reaction chamber, analyte binds also on the antibodies which are coated on the surface 
of the reaction chamber. Therefore, nanoparticle labels which have bound analyte will 
also bind to the surface. Sample is incubated at 37 °C for 15 minutes and then the 
chamber is washed with washing solution. Washing solution is driven from the washing 
solution chamber (7) to the waste chamber (8). It will remove all unbound particles 
from the reaction chamber leaving the specifically bound particles on the surface. In the 
last step fluorescence is measured using a time-resolved fluorometer and the original 
concentration of the analyte in the sample can be derived from the result. 
1.3 Overview of the thesis 
In this thesis, the performance of a sandwich immunoassay is studied in microfluidic 
cartridges. Especially, functionality of the reaction chamber is studied. Earlier studies 
have shown that there remain problems with unspecific binding of excess nanoparticles 
in the reaction chamber. This unspecific binding increases the noise in the measurement. 
Due to the noise, detection of small amounts of analyte is limited. 
1.3.1 Goal of the research 
The main goal of the study is to enhance the immunoassay performance by increasing 
sensitivity or decrease limit of detection by studying the effects of material and 
geometrical designs of the reaction chamber. A finite element method (FEM) model of 
reactions in the reaction chamber was developed. The purpose of modeling is to provide 
 4 
a better understanding of what happens inside the chamber. When these phenomena are 
understood, the model can be used to design a better functional chamber for the 
cartridge.  
1.3.2 The structure of the thesis  
The structure of the thesis is following. Chapter 2 includes theory and literature review 
of the point-of-care (POC) diagnostics, microfluidics, immunoassays and the detection 
method. The basic principle of finite element method modeling is also presented. 
Chapter 3 discusses materials and methods used to perform immunoassays. In the same 
chapter, developed models are described. Chapter 4 presents results and discusses the 
reasons for the results. Chapter 5 includes final conclusions and future development 
ideas.  
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2 LITERATURE REVIEW AND THEORY 
This chapter describes literature review and theory part needed in understanding the rest 
of the thesis. First, the point-of-care concept is introduced to give some background 
knowledge needed to understand what the thesis is about. The second section introduces 
the microfluidic concept and its phenomena. The third section explains immunoassay 
principles and the fourth section introduces interferences these immunoassays may 
have. The fifth section explains parameters affecting the immunoassay performance. 
Especially term sensitivity is explained there. In the sixth section, time-resolved 
fluorescence as a detection method is explained. The seventh section describes shortly 
the idea of finite element method modeling. 
2.1 Point-of-care diagnostics 
2.1.1 In vitro diagnostics  
In vitro diagnostics (IVD) includes all diagnostics where a sample is taken from a 
patient and measurements are done outside the patient. Typical samples are bodily 
fluids like urine, saliva or blood products from where different analytes like hormones, 
proteins and DNA are measured using different methods. IVD is usually done in 
centralized laboratories where patient samples are sent from surrounding hospitals. 
 
The revenues in Western Europe IVD market were over $ 13 110 million in 2011 and it 
is estimated to grow annually by 7.8 % and reaching revenues over $ 22 211 million in 
2018. Revenues of point-of-care testing (POCT) were only $ 1 535 million but it is one 
of the fastest growing segment in IVD market with the estimated annual growth of 8.5 
%. [1]     
2.1.2 Point-of-care testing 
Point-of-care testing is rapid in vitro diagnostics done near the patient. The idea of the 
POCT is that only small sample volume is needed, measurement can be done in minutes 
and care can be planned earlier compared to centralized laboratory tests. When adapting 
POC systems things happen faster. The doctor can get a result during one meeting and 
decide whether patient needs antibiotics or not. This helps to decrease the use of 
unnecessary antibiotics and reduces the time a patient stays in a hospital. Thus, 
developing and adopting rapid and cost-efficient POC tests would significantly improve 
public health care and decrease total expenses caused by the health care system.  
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Desired features for point of care diagnostics are (i) small reagent consumption for 
decreasing manufacturing costs and demanded sample volume to make tests minimally 
invasive and more convenient for the patient to take. (ii) Turnaround time, time from 
taking a sample to getting the results, should be less than 20 minutes which means that 
the test can be done, results can be analysed and future care can be decided during one 
doctor’s office meeting. In centralized IVD tests this is not possible due to sample 
deliveries and long measuring times. Delivery may also affect sample composition and 
thus it is possible to measure some analytes only right after taking the sample. [2–4] 
 
Generally centralized IVD gives more (iii) sensitive and (iv) specific results which are 
more (v) reproducible due to longer reaction times, but POC tests have been developing 
all the time and it is already more used for abundant analytes, like blood glucose or 
pregnancy tests. Portability (vi) is a significant benefit of POC devices as testing can be 
done in different environments like at a doctor’s office, at an ambulance, at an 
emergency site or at home. To be usable by untrained personnel (vii) the device must 
have a simple user interface, or even better, be as automated as possible. Environmental 
effects like the temperature or humidity caused by the location may affect performance 
and thus the device must be robust (viii) against such factors. Portability set also a 
demand for data transfer (ix) in situations where the user is not able to do an analysis or 
data is needed by surgeons to prepare a surgery of an incoming emergency patient. Data 
transfer is also needed for remote monitoring of patients at home care and for recording 
data into a patient database.  [2–4] 
2.2 Microfluidic principles 
Point-of-care applications are more and more based on microfluidics [5–7]. Size of 
these devices has become smaller and smaller during time and so has also the amount of 
fluids inside them. Controlling and handling of these small amounts of fluids is called 
microfluidics and in this section the basic principles of microfluidics are introduced.  
2.2.1 Fluid and scaling effect 
There are three states of matter: solid, liquid and gas. In the solid state matter is tightly 
packed together through molecular interactions and they have a strict lattice structure. 
For liquid and gas these interactions are much weaker and thus they do not have a strict 
order which would keep them in shape. These two states are together called fluids and 
they can be deformed by applying shear stress on them. [8] 
 
When scaling down the dimensions of a fluidic channel by ten, surface area is decreased 
by a factor of 102 and volume is decreased by 103. This means that a surface to volume 
ratio is increasing when dimensions are getting smaller. When the surface to volume 
ratio is increased enough, surface related physics are coming dominating over macro 
 7 
world physics. Conventional fluid physics does not apply and thus microfluidic 
principles are used. [8] 
2.2.2 Surface tension 
Surface tension is a liquid property where adhesive and cohesive forces on the liquid 
gas interface cause the surface to bend. In a bulk solution molecules are surrounded by 
other molecules and they are equally affecting each other. In the interface gas molecules 
are less dense and thus liquid molecules tend to draw interfacial liquid molecules 
inward. Surface tension, Ȗ, is usually presented as a force per unit length or energy per 
unit area. [8] 
2.2.3 Contact angle  
When a droplet of liquid is placed on the surface, it has a certain contact angle at a line 
between wetted and non-wetted surface. In two dimensions, the contact line is presented 
as a point and the contact angle (Figure 2.1) at this point can be calculated by Young’s 
equation: 
 
ߛ௅ீܿ݋ݏߠ = ߛௌீ െ ߛௌ௅         (2.1) 
 
Where ߛ௅ீ, ߛௌீand ߛௌ௅are surface tensions at liquid gas, solid gas and solid liquid 
interfaces, respectively. ߠ is the contact angle. [8] 
 
 
Figure 2.1 Droplet on a hydrophobic surface. Static contact angle is reached when 
surface tension forces are at balance along the solid surface. Figure from [9]. 
 
The contact angle is used for characterizing surface wettability and hydrophobicity. 
When it is over 90 ° for aqueous liquids, the surface is considered hydrophobic and non-
wettable. On the contrary the surface with the contact angle less than 90 ° is said to be 
hydrophilic and wettable. [8; 9] 
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Figure 2.2. Advancing and receding contact angles characterize surface properties 
more accurately compared to static contact angles. Figure from [9]. 
 
Dynamic contact angles (Figure 2.2), advancing (ߠ஺) and receding (ߠோ) contact angles, 
are measured by moving a droplet on a tilted surface or in the liquid channel. In this 
case there is hysteresis between the contact angles because an advancing meniscus of 
the droplet is moving towards dry, non-wetted surface and a receding meniscus is 
moving on the surface which is already wetted by the droplet itself. Hysteresis can be 
used to characterize surface properties like roughness, mobility and heterogeneity. [8; 9] 
2.2.4 Capillarity 
Capillarity phenomenon is usually explained with a rising liquid column inside a glass 
capillary but it also affects fluid flow in all microfluidic channels. The rising of the 
liquid column occurs due to contact forces between liquid and solid. Also cohesive 
forces causing the surface tension are included. The liquid column has a certain length 
when rising stops. In this equilibrium state forces at the contact line are in balance. 
Gravity of the liquid column has an effect on this height. In smaller channels, gravity 
has smaller effect than in a wider one and thus liquid rises more in the smaller channel. 
[10]  
 
In microfluidic channels capillarity can be exploited in controlling a fluid flow. The 
more hydrophilic surfaces the higher the capillary force is. In this case capillary force 
acts as fluid driving force causing fluid to flow inside the channel. On the hydrophobic 
surfaces, capillary force has an opposite effect and it prevents liquid from filling the 
channel. These physical properties can be used to act as a passive valve where capillary 
force prevents fluid flow due to the hydrophobic surface or due to sharp corners. The 
contact angle is used to characterize the strength of capillary force. [10] 
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2.2.5 Flow control 
In addition to capillary force, fluid flow can be generated with electro osmotic flow 
(EOF) [11] or with pressure [12]. Capillarity is used in paper-based [13] devices but 
recently developed digital microfluidic systems[14] exploit it by changing the wetting 
properties of the surface by electrodes. 
 
In EOF, channel walls are negatively charged and thus attract opposite charges from the 
bulk solution. An electrical double layer is formed and there is a higher density of 
charges near the wall compared with the middle of the channel. Thus, potential is 
decreasing when moving from the wall to the center of the channel. If an electric field is 
applied between channel ends, it will cause electrical force which begins to move 
positive charges towards a negative electrode. [8; 11] 
 
Pressure difference is the most traditional fluid control method. It can be easily applied 
either to single phase flows or two phase flows just by adding higher pressure on the 
inlet than on the outlet.  
 
Navier-Stokes equation is momentum balance equation used to predict fluid behavior: 
 
ߩ
ௗ࢜
ௗ௧
ൌ െߘ݌ + ߩࢍ + ߤ[ߘଶ࢜+ ଵ
ଷ
ߘ(ߘ ή ࢜)]      (2.2) 
 
Where ߩ is the density of the fluid, ࢜ is the velocity vector, t is time, p is pressure, ߤ is 
the dynamic viscosity of the fluid and ࢍ is the gravity vector. As fluids are many times 
assumed to be incompressible (constant ߩ) Newtonian fluid (constant µ) the equation is 
simplified to form: 
 
ߘ ή ࢜ = ૙          (2.3) 
 
ߩ
ௗ࢜
ௗ௧
ൌ െߘ݌ + ߩࢍ + ߤߘଶ࢜        (2.4) 
 
For very slow fluid motion in a micro channel this equation simplifies further to  
 
ߘ݌ = ߤߘଶ࢜          (2.5) 
 
As the first derivative can be neglected due to slow velocity and gravity is neglected 
because of a small volume. [8; 12] A constant pressure drop inside the channel with a 
flow rate, ܳ, can be described with equation: 
 
ο݌ = ܴ௛௬ௗܳ, ܴ௛௬ௗ = ଼గ ߤܮ ଵ௥೎೓ೌర       (2.6) 
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Where ܴ௛௬ௗ is the hydraulic resistance of a channel. The hydraulic resistance of a 
circular channel is given as an example. ݎ௖௛௔ is the radius of the circular channel and ܮ 
is the length of the channel. 
2.2.6 Plug flow 
In plug flow, the channel contains at least one plug of liquid which is separated by 
another liquid or gas (Figure 2.3). Pressure can be used to move this liquid plug, but in 
addition to fluid friction there is also capillary force affecting both ends of the plug. 
Thus total pressure drop in the channel is 
 
ο݌௖௛௔௡௡௘௟ ൌ ο݌ௗ௥௔௚ ൅ ο݌௖௔௣        (2.7) 
 
Pressure drop due to fluid friction for the circular channel is written as 
 
ο݌ௗ௥௔௚ = ଼௩௥೎೓ೌమ (ߤଵܮଵ + ߤଶܮଶ)       (2.8) 
 
Where ݒ is the average velocity of the fluid, ݎ௖௛௔ is the radius of a circular channel, ܮଵ 
and ܮଶ are total lengths of the plugs of fluid 1 and 2. ߤଵ and ߤଶ are dynamic viscosities 
of the fluid 1 and 2. 
 
 
Figure 2.3. In plug flow friction forces are affecting inside the fluid (between A-B C-D 
and E-F) and capillary forces between surfaces (B-C and D-E) [15]. 
 
Capillary force is acting on the plug interfaces and magnitude of the pressure drop is 
related to contact angles on the advancing,ߠ஺, and receding meniscus, ߠோ, as   
 
ο݌௖௔௣ = ଶఊ௥೎೓ೌ ሺെܿ݋ݏߠ஺ + ܿ݋ݏߠோ)       (2.9) 
 
Where ߛ is the surface tension at interfaces Pressure always decreases from inlet to 
outlet but over the receding interface it may temporarily increase when the receding 
contact angle is more than 90°.[15] 
2.2.7 Laminar flow 
Reynolds number (Equation 2.10) characterizes the quality of the fluid flow. It 
represents the ratio between inertial forces to viscous forces in the fluid. 
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ܴ݁ = ఘ௩஽೓೤೏
ఓ
ǡ ܦ௛௬ௗ = ସ஺௉         (2.10) 
 
Where ߩ is the density of the fluid,  ݒ is the average flow velocity in m/s, ߤ is the 
dynamic viscosity of the liquid and ܦ௛௬ௗ is the hydraulic diameter of the channel. ܣ is 
the cross sectional area of the channel and ܲ is  the  perimeter  of  that  area.   When the  
Reynolds’s number is less than 2000, fluid flow is considered fully laminar. Between 
2000 and 4000 is the transition stage and above 4000 flow is fully turbulent. [8] For 
example, the channel used in the thesis is 0.5 mm high, ݄, and 2 mm wide, ݓ. The 
highest flow rate used in the channel is 3.25 ml/min. When water at 20°C temperature is 
flowing through the channel, Reynolds number is approximately 43.  
 
Scales of microfluidic systems are so small that fluid flow is fully laminar. In laminar 
flow, fluid is flowing in layers along each other parallel to walls. In this kind of flow 
lateral mixing is mainly diffusion based. [8]  
 
2.2.8 Diffusion 
Diffusion is a mass transfer phenomenon which occurs due to the random Brownian 
motion of the molecules. In gas or liquid, molecules vibrate and move straight until they 
collide with other molecules. On a collision molecules change the direction until they 
collide again. Although bulk solution does not seem to move, molecules inside it are 
moving randomly all the time. This temperature dependent vibrational movement is the 
physical explanation for diffusion. [16] 
 
A fundamental example of diffusion is bulk solution which is divided with a non-
permeable membrane and each side of the membrane has different concentration (the 
amount of substance in unit volume [mol/l] = [M]) of molecules. When the non-
permeable membrane is removed, molecules are unevenly distributed in the bulk 
solution. A concentration gradient is formed at the place where the membrane was 
removed. After some time, molecules spread due to the Brownian motion to cover the 
whole bulk solution and distribute evenly over the whole volume. During this process, 
the concentration gradient widens and in the end disappears. [16] 
 
To describe this gradient based molecular movement Adolf Fick developed Fick’s law 
for one dimensional flux ࡺ࢏ as 
 
ࡺ࢏ ൌ െܦ௜
డ௖೔
డ௫
          (2.11) 
 
Where ࡺ࢏ is flux per unit area, ܿ௜ is concentration, ݔ is distance along axis x and D is 
the diffusion coefficient. In three dimensions, Fick’s law is presented as  
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ࡺ࢏ ൌ െܦ௜ߘܿ௜          (2.12) 
 
This can be explained in the following way. Flux will occur in a direction of the 
negative gradient (from higher to lower) of concentration with the speed of a diffusion 
coefficient D. First law is used to derive Fick’s second law to present time dependent 
change in concentration  
 
డ௖೔
డ௧
= ܦ௜ߘଶܿ௜          (2.13) 
 
The diffusion coefficient is a natural constant which is dependent of the molecule or 
particle. There are many estimates for it but maybe the most common one is Stokes-
Einstein equation 
 
ܦ௜ = ௞ಳ்଺గఓ௥೔          (2.14) 
 
Where ݇஻ is Boltzmann’s constant, T is the temperature in kelvins, µ is the dynamic 
viscosity of the solvent and ݎ௜ is the radius of the solute. This equation is used to 
estimate the diffusion coefficient for spherical molecules which are much larger than 
comparison with the molecules of the surrounding solvent. [16] Diffusion distance, ݀, 
can be written as 
 
݀ = ඥܦ௜ݐ          (2.15) 
 
Here ݐ is the diffusion time. This means that a particle which has the larger diffusion 
coefficient will move faster over a certain distance. Diffusion limits the mixing speed 
and thus small dimensions are favorable to ensure fast chemical reactions. Different 
micro mixer structures and methods have been developed to overcome limitations 
caused by the diffusion in the micro scale.  [16; 17] 
2.3 Immunoassay 
Immunoassays are analytical methods used to detect an analyte and to quantify the 
concentration of it. Immunoassays have been used widely in in vitro diagnostics for 
their simple structure, rapid and sensitive detection for versatile analytes. There are 
several different immunoassays. Immunoassay can be homogeneous or heterogeneous, 
competitive or non-competitive and there are several different detection methods. A 
structure and a detection method of different assays may vary but all immunoassays 
have one common element: they all exploit specifically binding antibodies (Ab).   
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2.3.1 Antibodies and antigens  
Antibodies are proteins produced by a living creature. Immune system uses these 
proteins to recognize different types of antigens (Ag) inside the body. If a foreign 
antigen is detected, the immune system begins to produce more antibodies against this 
foreign “pathogen” and tries to prevent it from spreading and causing disease. There are 
several types of antibodies produced inside the body and immunoglobulin G (IgG) is the 
most abundant. [18] 
 
The basic structure of an antibody (Figure 2.4) is usually described as a Y-shape protein 
of four polypeptide chains. It has two similar heavy chains and two similar light chains, 
which are bound together through disulphide bonds. These chains can be further divided 
into constant and variable domains depending on amino acid variability. [18] 
 
 
Figure 2.4. The structure of an antibody. Two heavy chains (blue) and two light chains 
(orange) are bound together with disulphide bonds (red). The antibody has two Fab-
fragments and one Fc-fragment. Constant domains are colored with dark and variable 
domains with light color.  
 
Variable domains on N-terminus of the peptide chains are part of the antibody binding 
fragments (Fab), which are key regions in detecting different antigens. Structure of the 
fragments enables specific binding to a specific region (epitope) on the antigen. The 
fragment crystallisable (Fc) part is located in C-terminus of heavy chains and it has an 
important role in immunological responses after antibody-antigen interaction. [18] 
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Fab’s and Fc regions are the most important parts of the antibody, but there are also 
some carbohydrate and primary amine groups which can be used for labeling  or 
attaching the antibody on a surface. [18; 19] 
2.3.2 Heterogeneous vs. homogeneous immunoassays  
The immunoassay methods are divided into two main branches. In homogeneous 
assays, all molecules are free and all reactions take place in solution. Special labels have 
to be used in homogeneous assays. The label must be detectable either when the antigen 
is free or bound on the antibody, but not in both cases. All substances can be mixed 
together and separation is not needed. This makes homogeneous immunoassays very 
fast and easy to perform. [20] 
 
In heterogeneous immunoassays antibodies or antigens are attached to the surface and 
they are used to capture the desired antigen or antibody from the sample. Labels used do 
not make the difference between binding reactions as in the homogeneous case and thus 
all excess unbound labels must be separated from the surface by a washing procedure. 
[20] 
2.3.3 Competitive vs. non-competitive assays  
The immunoassay methods can be further divided into competitive and non-competitive 
assays. In the competitive immunoassay, a certain amount of labeled antigen is added to 
solution with the unlabeled antigen of interest. These antigens compete for limited 
binding places. The more unlabeled antigen there is the more it will displace labeled 
antigens. Hence signal will decrease when the analyte concentration is increasing. 
Competitive immunoassays are usually performed for small univalent analytes having 
only one epitope. [20] 
 
In the non-competitive immunoassays, the detected signal is directly proportional to the 
amount of bound antigen. Non-competitive immunoassays demand a sandwich 
structure: Antigen bounds to capture antibodies on the surface. To detect bound 
antigens, labeled tracer antibodies are added on the surface on top of bound antigens. 
Tracer antibodies bind on antigens and form a sandwich structure. In the end, labels are 
used to measure the number of bound tracer antibodies on the surface and the relation 
between them and antigen concentration is used to calculate the original amount of 
antigen in the sample. [20] Non-competitive assays are usually performed with reagent 
excess. This means that the amount of tracer antibodies and the number of binding 
places on the surface overcome the number of antigens on the sample. This way the 
number of bound antigens and the number of tracer antibodies are maximized. 
 
Both heterogeneous competitive and non-competitive sandwich assays can be done 
either with one step or with two steps. In non-competitive assay which is done in one 
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step, tracer antibodies and antigens of interest are mixed together with a known amount 
of capture antibodies. Immunocomplexes, which contains capture antibodies bound to 
tracer antibodies by the antigen, are formed and measurement is done after washing all 
unbound labels away. In two steps assay, the antigen of interest forms the first 
immunocomplex with capture antibodies and all unbound antigens are washed from the 
surface. In the second step, tracer antibodies are added to surface to form the full 
immunocomplex. After this, the surface is again washed to remove all excess labels 
from the surface. Two step assay formats usually provides higher sensitivity and 
specificity compared with one step assays. [20] 
2.3.4 Basic immunoassay reactions and reaction rates 
Antibody binding can be described as a chemical reaction where the separate antibody 
and antigen are reactants and form an antibody-antigen complex as a final product. For 
the simple case where the antibody has only one binding place the reaction can be 
written as: 
 
ܣܾ + ܣ݃݇௔֎
݇ௗ
ܣܾܣ݃         (2.16) 
 
Where Ab is the antibody, Ag is the antigen and AbAg is antibody-antigen complex. 
Two sided arrows indicate that the reaction can occur in both directions. In other words, 
reaction is reversible. [21] 
 
A reaction rate is a definition how much the concentration of certain reactant or product 
is changing as a function of time. The concentration of bound analyte is measured in 
immunoassays and thus reaction rate for antibody-analyte complexes is an important 
factor which has to be taken into account when designing immunoassays. This reaction 
rate, ܴ, can be derived from the reaction equation: 
 
ܴ = ௗ[஺௕஺௚]
ௗ௧
= ݇௔[ܣܾ][ܣ݃] െ ݇ௗ[ܣܾܣ݃]      (2.17) 
 
The concentration of a substance is marked with square brackets. Parameters, ݇௔ and ݇ௗ 
are reaction rate constants for association and dissociation reactions, respectively. 
Reaction rate constants tell how fast reactions occur when reagents collide. Collisions 
are related to the concentrations of the substances and thus they are also included in the 
equation. The reaction rate equation can be explained by the following way. First part 
comes from an association reaction where complexes are formed depending on the 
concentrations of antigens and antibodies. Second part is for a dissociation reaction 
where complex is taken apart and thus it has a minus sign. [21] 
 
 16 
Reaction rates are used for modeling chemical reactions and two parameters which can 
be easily studied are initial reaction rate and steady state approximation. At the 
beginning of the reaction there are only initial concentrations for antibodies and 
analytes, [ܣܾ]଴ and [ܣ݃]଴ respectively. The concentration of complexes is zero and thus 
the initial reaction rate, ܴ଴,  can be written as: 
 
ܴ଴ = ௗ[஺௕஺௚]బௗ௧ = ݇௔[ܣܾ]଴[ܣ݃]଴       (2.18) 
 
In a steady state there occurs reactions both directions all the time but they occur at the 
same rate and thus it seems that nothing is happening. The system is in equilibrium and 
the total reaction rate is assumed to be zero. The steady state approximation is used to 
estimate the final concentrations of different compounds: 
 
 
ܴ = ௗ[஺௕஺௚]
ௗ௧
= ݇௔[ܣܾ][ܣ݃] െ ݇ௗ[ܣܾܣ݃] = 0     (2.19) 
 
݇௔[ܣܾ][ܣ݃] = ݇ௗ[ܣܾܣ݃]        (2.20) 
 
ܭ஺ = ௞ೌ௞೏ = [஺௕஺௚][஺௕][஺௚]         (2.21) 
 
Where ܭ஺ is an association constant. Dissociation constant, ܭ஽, is an inverse of the 
association constant. These are reaction rate parameters which are usually provided by 
antibody producers. [21] 
2.4 Interferences in immunoassay 
Immunoassays are effective tools for measuring analyte concentrations from the bodily 
fluids, but there are several interferences which may cause erroneous results. In this 
section, these interferences are shortly introduced and basic procedures for avoiding 
them are presented.  
2.4.1 Unspecific binding of the label on the surface 
Even though there are no antigens in the sample a small number of the label particles 
will stick to the surface. This phenomenon is called unspecific binding. These un-
specifically bound labels lead to a higher noise level and usually also to a higher 
deviation of the noise. Thus unspecific binding is reducing a signal to noise ratio and 
more important, causing a higher limit of detection for the assay. There are several 
reasons why unspecific binding occurs. First, adsorption can occur straight to an 
exposed material surface. To prevent this surfaces are usually modified with self-
assembling monolayers or some strong adsorbing protein which would form a 
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protective layer against unspecific adsorption. Second, it is possible that capture 
antibodies on the surface bind to the tracer antibodies. Reason for this may partially be 
in carbohydrate and amino groups of the antibodies. Third, the surface may have a 
structure or shape which fastens the label on the surface. [22; 23] 
2.4.2 Hook effect 
If the measurement signal is presented as a function of concentration, the signal usually 
rises due to bound labels. After a certain concentration, the signal starts to decrease and 
forms a hook. This is called the hook effect and it is caused by an antigen excess in the 
system. Antigen molecules bind to capture antibodies and labeled antibodies. When 
there are enough antigens all binding places from both the capture and label antibodies 
become filled. Thus the label antibodies do not bind as efficiently to the capture 
antibodies and the measured signal decreases as the antigen concentration increases. 
[23; 24] 
 
Erroneous results caused by the hook effect can be avoided by a couple of means. 
Usually the sample is diluted enough to be certain that the concentration is on the rising 
side of the hook. This can be done when the sample is well known and usual 
concentration values are familiar. On the opposite it is possible to use reagent excess of 
antibodies to be sure that binding sites will not come saturated. Last method is to 
perform the assay in two steps using washing between antigen incubation and label 
antibody incubation. [23; 24] 
2.4.3 Cross reactive substance  
Antibodies are not perfectly specific for certain antigens. There may be substances in 
the sample which have similar structures as the antigen which is wanted to measure. In 
this situation, antibodies cross react with these molecules and cause distorted results. 
This is mostly causing problems in competitive immunoassays due to an extra 
competitor. Sandwich assays are more specific as there are two different antibodies 
which are binding to the antigen. As antibodies are binding at the same time it is less 
probable that both of them can bind to a substance other than the antigen. [24] 
2.4.4 Anti-animal antibody interference 
Blood contains several antibodies which can either react with antibodies used in the 
assay or with the measureable antigen and thus cause interference in the immunoassay. 
Human anti-animal antibodies (HAAA) are able to recognize animal antibodies with 
high specificity. HAAAs can bind either to a constant or a variable part of the animal 
antibody. If animal antibodies are used as capture or tracer antibodies, it is possible that 
HAAAs attach to them and prevent antigen or tracer binding on the surface. This leads 
to a false negative result. On the other hand, if HAAAs are able to bind to both tracer 
and capture antibodies, the result is false positive. Interferences are mainly avoided by 
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carefully planning the assay design and what kinds of antibodies are used in it. Other 
way is to remove HAAAs by a sample pre-treatment. [25] 
2.4.5 Matrix effect 
Immunoassays are quite sensitive to the environmental conditions of the sample, also 
called a matrix of the sample. Ionic strength, pH and protein and lipid concentrations of 
the sample are affecting the reactivity of antibodies. Composition of the blood varies a 
lot between different people and thus matrix effect may cause different results for 
different people. Matrix effect is minimized by diluting the sample in the buffer 
solution. This way, environmental factors are tried to be kept constant for every sample. 
[24] 
2.5 Detection methods 
There are several different detection methods for immunoassays which can be divided 
in to two main categories: techniques which use labeled molecules for detection and 
techniques which are label-free.  
 
First immunoassays used radio-isotopic labels (radio-isotopic immunoassay or RIA) 
[26]. These labels have some disadvantages and they have been replaced by labels like 
fluorophores in fluorescence immunoassays (FIA) and by enzymes in the enzyme linked 
immunosorbent assays (ELISA). FIA and ELISA are nowadays two most used detection 
methods. New labels are developed all the time and especially the use of quantum dots 
and nanoparticles is increasing. [27] In this thesis, a time-resolved fluorescence method 
was used as a detection method for the immunoassay. Basics of the method are 
explained in the next section. 
 
Label-free detection methods are typically based on the change of mass over a specific 
surface. There are several different method to detect the change in the mass like surface 
acoustic waves [28], piezo resistive cantilevers [29] or a surface plasmon resonance 
[30]. 
2.5.1 Time-resolved fluorescence 
Fluorescence is the form of luminescence where molecules are excited with the photons 
having a certain wavelength. In excitation, the energy of the photon is adsorbed by an 
electron that jumps from a lower energy level to a higher one. Because electrons tend 
towards a minimum energy state, the electron soon returns to a lower energy level 
where it originally was. Usually, the electron returns to a lower level in two phases. 
First it goes through non-radiating transition where part of the gained energy is lost as 
heat. In the second phase there occurs a radiating step where the rest of the energy is 
released as a photon. As part of the excitation energy is lost in the non-radiating 
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transition, the emitted photon has lower energy and thus also longer wavelength than the 
exciting photon.  
 
Traditional fluorophores usually have a very short emission lifetime, less than 100 ns. In 
time-resolved fluorescence a special type of fluorophores are used. Some lanthanide 
chelates, like Europium(III), Dysprosium(III),Terbium(III) and Samarium(III), have a 
very long emission lifetime spanning from 10 to 100 µs. This ensures that background 
fluorescence from excitation light is already diminished when the actual measurement is 
done (Figure 2.5). This way most of the measured signal is caused only by the labels, 
which afford high sensitivity to the measurement. [31; 32] 
 
 
Figure 2.5. The basic principle of the time-resolved fluorescence measurement: The 
sample is first excited with a certain, high energy, light pulse. A photon count 
measurement is done from a certain time interval after background fluorescence is 
diminished. 
 
Other advantage of the lanthanide chelates is a large stokes shift. The Stokes shift 
means the difference between the excitation and the emission wavelengths. With 
traditional fluorophores excitation and emission wavelengths are overlapping. Due to 
this, the separation of these wavelengths using optical filters is challenging. With 
lanthanide chelates, the stokes shift is larger and there is no overlapping between 
excitation and emission wavelengths. This makes the separation easier than with 
traditional fluorophores. [31; 32] 
 
Lanthanide chelates (Figure 2.6) are compounds where a lanthanide ion is bound to an 
organic chromophore via metal binding groups (chelators). Lanthanide ions are difficult 
to excite directly. Instead, of exciting lanthanide ions, the organic chromophore is used 
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to adsorb excitation energy. Energy is transferred to the lanthanide ion which then emits 
photons with narrow bandwidth. Chelates are sensitive to the environment and for 
example water and some heavy metals [33] are known to quench their fluorescence 
signal. In quenching, the excitation energy is transformed fully to heat and thus photons 
are not generated. [34; 35] 
 
 
Figure 2.6. Example of an europium(III)-chelate. Eu(II1) 4’-(3-amino-4-
methoxyphenyl)-6,6”-bis(N,N-bis(carboxymethyl)aminomethyl)-2,2’: 6’,2”-terpyridine. 
Figure from [35] 
 
2.5.2 Europium nanoparticles 
In europium nanoparticles, chelates are embedded inside a polystyrene shell. The first 
advantage of the shell is that it protects the chelates from environmental effects and this 
way prevents quenching. Secondly, it is possible to have several thousand chelates 
inside a single nanoparticle. This way the label provides a much higher intensity 
compared with a single antibody which does not have as many chelates. [34]  
 
The polystyrene shell itself contains carboxylic acid groups which can be used to couple 
antibodies on the surface of the nanoparticle [36]. Doing so it is possible to increase 
binding places on the particle and thus nanoparticles have increased reaction rates [37]. 
With these properties europium chelate nanoparticles has shown to have high sensitivity 
over individually labeled antibodies.  
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2.6 Parameters affecting assay performance 
This section discusses the evaluation of immunoassay performance and presents 
parameters related to the immunoassay performance. Sensitivity is one of the most used 
terms when speaking about assay performance. Unfortunately, it has many meanings 
and thus it might be used in a confusing way. Thus, different definitions of sensitivity 
are discussed first. 
 
2.6.1 Sensitivity 
There are three different kinds of sensitivities which are used when speaking about 
immunoassays: measurement sensitivity, analytical sensitivity and clinical sensitivity. 
As all of these have completely different meanings it is important to know the 
difference between them. 
 
Measurement sensitivity is commonly used in the field of measurement technology. [38] 
It is used to describe how measurement result changes within the linear range of the 
measurement (Figure 2.7). In other words, it is the slope of a measurement curve in the 
linear range: 
 
ܵ݁݊ݏ݅ݐ݅ݒ݅ݐݕ = οௌ௜௚௡௔௟
ο஼௢௡௖௘௡௧௥௔௧௜௢௡
        (2.22) 
 
Further on in this thesis the term sensitivity refers to the measurement sensitivity. 
 
The second term is analytical sensitivity which is also called a limit of detection (LOD). 
It defines the smallest amount of concentration which can be detected with a 
measurement device. [39] It is calculated as: 
 
ܮܱܦ = ଷఙಿ
ௌ௘௡௦௜௧௜௩௜௧௬
         (2.23) 
 
Here ߪே is the standard deviation of the signal noise. This equation gives 99.87% 
confidence that LOD value is not a part of the noise. Further on in this thesis, LOD is 
used to avoid confusion with the measurement sensitivity. [39] 
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Figure 2.7. Signal to concentration of a measurement to clarify the difference between 
sensitivity and limit of detection. Hook effect can be seen after linear range. 
 
Clinical sensitivity is the term used in clinical studies. It is statistical value which 
describes how well the test will correctly identify diseased patients [40]: 
 
ܥ݈݈݅݊݅ܿܽݏ݁݊ݏ݅ݐ݅ݒ݅ݐݕ = ்௥௨௘௣௢௦௜௧௜௩௘
்௥௨௘௣௢௦௜௧௜௩௘ାி௔௟௦௘௡௘௚௔௧௜௩௘
     (2.24) 
 
True positive means that a patient has disease and the test result is positive. False 
negative means that a patient actually has the disease, but the test result is negative. As 
the cartridge is still in a development phase this parameter is not yet needed. 
2.6.2 Material and surface roughness 
Material properties have a big effect on how proteins are adsorbed on the surface. 
Proteins have regions which can interact with the material surface by many means like 
hydrophobic or hydrophilic interactions or through positive or negative charges etc. [41]  
These interactions not only define how proteins stay on the surface as they have been 
adsorbed but also how they maintain their structure. This is important as heterogeneous 
immunoassays are relying on coatings which can specifically capture the certain 
antigen. It is important to have a high capacity surface where antibodies are aligned 
correctly and retained their functionality to capture the antigen. Such a surface offers a 
lot of specific binding places for the antigen and leads to higher signal values. 
 
In addition to the material, the roughness of the surface also affects adsorption and 
protein folding. Additional to this the total surface area can be increased with micro and 
 23 
nanostructures. This way the amount of binding places on the surface can be increased 
which leads to higher fluorescence signals. [42; 43] 
2.6.3 Reaction time 
Immunoreactions eventually reach the steady state situation where as many binding 
reactions as detaching reactions happen. In this balance situation the maximum number 
of antigen bindings is reached and thus the signal values are the highest. Unfortunately 
reaching this situation normally takes several hours.  
 
In point-of-care applications results are desired as soon as possible. Using shorter times 
means that the reactions are stopped as they are still going on. Thus the signal levels of 
the result are lower than with assays where the steady state is reached. This affects the 
overall performance of the assay as the measurement sensitivity is lower.  Deviation in 
assay time also has a more significant effect on signal values in short time incubation 
compared with a longer incubation. 
2.6.4 Temperature 
The temperature affects molecular vibrations. In higher temperature, more molecules 
will vibrate. Diffusion is based on random vibrations and thus the temperature 
influences the diffusion coefficient (Equation 2.14).  
 
Reaction rates also depend on the temperature as more vibrations means that there will 
be more collisions between molecules and thus more possibilities for reactions to occur. 
Unfortunately, as antibody reactions are reversible also dissociation reactions are 
affected by the temperature. Thus it is not so straightforward to say how the temperature 
affects reaction rates. Increase in the temperature increases antibody activity, but high 
temperatures will cause denaturation and molecules lose their functionality [44]. In this 
thesis, the temperature is not studied as it was seen best to mimic the nature and use 36 
°C temperature.  
2.6.5 Concentrations 
Concentrations have an effect on the overall assay through reaction rates. The more 
there are initial substances the more equilibrium will move towards the end products. 
Most of the immunoassays rely on a reagent excess. This way, most of the antigens will 
react with label and capture antibodies. Usually the density of specific binding places is 
maximized to reach high reaction rates and signal values.  
 
The only drawback in the reagent excess method is that as there occur nonspecific 
binding on the surface the number of label molecules have to be optimized. If there are 
too few labels, it means that signal levels would not be as high as with higher label 
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concentrations. On the contrary if label concentration is too high unspecific binding will 
occur and thus the noise level increases.   
2.6.6 Shape of the reaction chamber 
A shape of the reaction chamber in a microfluidic cartridge defines the amount of the 
sample which can be used. If the immunoassay is performed using stationary 
incubation, the assay will be diffusion limited. Thus it is useful to know how large 
volume is reasonable to perform accurate measurement.  
 
More important is the fluid flow through the chamber. If there are any bubbles 
generated inside the chamber, they may prevent immunoreactions from taking place or 
prevent the proper washing of the excess labels. In both cases the final results will be 
erroneous. 
2.7 Finite element method modeling 
The finite element method (FEM) is a numerical technique used to discretely 
approximate solutions for partial differential equations (PDEs). PDEs are represented in 
a matrix form which is solved depending on applied loads. The finite element method 
was first used in structural mechanics but in this case a microfluidic system is used as an 
example. Given description is a very simplified version of the whole process. More 
detailed information of the FEM can be found in the book “The finite element method” 
written by Zienkiewicz and Taylor [45; 46].  
 
In the FEM modeling a system is presented with geometry. The geometry is divided 
into smaller elements (Figure 2.8), which are connected to each other via nodes. These 
nodes are used for creating a stiffness matrix for a model in such way that a node is 
basically affected only by its neighbor nodes in certain manner. The effect of the 
neighbor node is described with PDEs of the studied physics and node positions are 
taken in to account in forming final equations which describe the system. In a fluidic 
system Navier-Stokes equation (Equation 2.2) would be used to describe fluid flow. [45; 
46] 
 
The way domains in the geometry are defined is called domain conditions. As there can 
be more than one material inside the geometry there can also be multiple subdomains 
where physics are defined in a different way. For example, in the plug flow the 
geometry will contain domains for gas and liquid materials. 
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Figure 2.8. Basic idea of FEM. Boundary conditions are marked with different colors. 
 
As the system is finite, it has some boundaries. These boundaries have to explain the 
relation between the system and the outside of the system. These relations are called 
boundary conditions. For example, when modeling a fluid flow through the system one 
has to define an inlet, an outlet and walls for the system. All the nodes in the inlet 
boundary have to be defined in such a way that matter can flow in to the system. If 
nodes on walls are defined to be rigid and non-permeable, the model should also have 
the outlet for the matter. This way an impossible situation where infinite amount of 
matter would fill the finite volume is avoided.  
 
The basic idea of the FEM is that solution is gained through matrix calculation where a 
displacement matrix, a, is solved related to a stiffness matrix, K, and applied loads or 
external force r: 
 
ࡷࢇ = ࢘ െ ࢌ          (2.25) 
 
In here ࢌ stands for forces needed to balance the distribution of load force and initial 
strains over elements. For the fluid flow example, the load means pressure on the inlet 
and the outlet. Pressure difference will cause the certain fluid flow rate inside the 
system. In this case the displacement matrix would present a velocity field of the fluid 
inside the system. [45; 46] 
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In most FEM software, all models are created through the same basic steps: 
 
1. Create a geometry 
2. Define domain and boundary conditions 
3. Mesh geometry 
4. Solve the system 
5. Post process the results  
 
The first step is to draw the geometry or importing it to software from a separate file. In 
the second step the user defines domain conditions. This means setting correct material 
parameters for the geometry. In chemical models, domain conditions define 
concentration and the diffusion coefficient etc. In the same step one defines how 
different boundaries act. Where are the walls, inlets and outlets. In other words, these 
are loads applied to the system.  
 
The third step is meshing, where the geometry is divided into smaller pieces. Elements 
and nodes are used to assembly the stiffness matrix. The challenge in meshing is to 
reach balance between model accuracy and simulation time. The denser the mesh is the 
more accurate results are gained. On the contrary, if mesh is too dense it will result in 
the large stiffness matrix and thus it will take more time to solve the system. In some 
cases it is even possible that a computer run out of memory due to large matrices. A 
smaller mesh is easier to solve but it will generate a less accurate result. In the end, 
model is solved and results are post processed to presentable form. [47] 
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3 MATERIALS AND METHODS 
This chapter presents all the practical work done for the thesis and all the equipment 
used to fulfill different tasks. First, cartridge geometries and fabrication methods are 
described. Second section explains the coating of the immunoassay surfaces and 
experiments done with them. Third section explains the used models. 
3.1 Cartridge for immunoassay 
Thyrotropin (TSH, thyroid stimulating hormone) immunoassay was used as a model 
assay due to the fact that TSH is a quite well known analyte. Cartridge fabrication and 
antibody coatings and method to perform immunoassays are explained next. 
3.1.1 Used Geometries  
Three kinds of reaction chambers are used in the experiments. Chamber 1 is the original 
chamber of the NanoFlow cartridge (Figure 1.1) which was 12 mm long, 4 mm wide 
and 0.5 mm high. Volume of the chamber was 40 µl and area of the reaction area was 
approximately 54 mm2.  
 
Chamber 2 (Figure 3.1a) is a more simplified one. It is actually just a widened part of a 
2 mm wide and 0.5 mm high channel. The chamber is 4.5 mm wide and 14.5 mm long. 
Height is constant 0.5 mm. The volume of the chamber is 27 µl and the reaction area is 
68.08 mm2. This chamber is used in material comparison. 
 
Figure 3.1. The structures of the reaction chamber inserts used in the thesis. 
 
Chamber 3 (Figure 3.1b) is designed as a result of the FEM models. Instead of having a 
reaction chamber with large volume, a narrowing in the channel is used as the reacting 
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surface. The narrowing was 6 mm long where 2 mm of the middle has a constant height 
of 150 µm. The chamber has small 50 µm barriers at the beginning and at the end of the 
reaction area. Purpose of these barriers is preventing coating solutions spread in the 
channel. The reaction area was around 5.1 mm2. Chamber volume is around 0.8 µl. 16 
µl sample is used to fill the whole chamber. The idea of the narrowing is to test the 
effect of chamber height on the immunoassay with stationary incubation. On the other 
hand, as the narrowing works as a passive valve, it can be used to control reciprocating 
flow over the reacting surface. Moving the sample during incubation increase the mass 
transfer of the particles towards the reacting surface and will lead to higher signal 
values.  
 
As mentioned earlier, increased surface roughness and microstructures would increase 
the amount of protein adsorption on the surface. This will be tested by making 
microstructures in the reaction area of the Chamber 3. Molds for the chamber are done 
in University of Eastern Finland where micro cavities are laser ablated in the reaction 
area with a femtosecond laser [48]. These cavities should be replicating to the plastic 
cartridge as microstructures increasing total surface area and thus increase signal levels.  
 
The Chamber 3 had some problems with capillary effect, which caused bubbles to 
occur. Thus it had to be modified. For the Chamber 4 (Figure 3.1c), the channel cross-
section was changed to a half circular shape which has 0.5 mm radius. To get the same 
amount of sample to fit inside the channels they were lengthened. Second, the chamber 
height was increased to 200 µm and barriers were removed. Chamber edges were also 
rounded with a radius of 100 µm. 
3.1.2 Injection molding  
Two types of injection molded cartridges are used as a substrate for the immunoassay 
(Figure 3.2). The NanoFlow cartridge has all microfluidic components while the insert 
cartridge is used to test an individual component. In this thesis different chamber 
geometries are used in the insert cartridge. Fabricating new molds is cheaper as only a 
small part of the mold is needed to change instead of the whole mold. 
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Figure 3.2. Laser welded cartridges used in the thesis. The NanoFlow cartridge is on 
the left and one of the insert cartridges containing the Chamber 2 and the Chamber 4 is 
on the right. 
 
The NanoFlow cartridges were injection molded from a high-impact polystyrene grade 
Styrolux 656C (Styrene-butadiene copolymer from Styrolution). Injection molding was 
done by Plastone Oy (Nurmijärvi, Finland). Injection moldings of the insert cartridges 
were done in the Polymer laboratory of Tampere University of Technology. Three 
different PS grades, Styrolux 656C (styrene butadiene copoplymer (CBS) from 
Styrloution), PS 158K (general purpose PS from BASF) and Empera 124L (general 
purpose PS from Ineos-Nova) were used in these cartridges. Also a PMMA grade LG 
PMMA HI 835M (Ides) was used for a comparison. For the Chamber 4 experiments, 
KR-01 grade SBC (from K-resin) was used as Styrolux 656C was temporarily out of 
stock.  
3.1.3 Reaction chamber coating 
The injection molded plastic cartridges were first cleaned by rinsing them in 
isopropanol, then washed with deionized water and dried with compressed air. In the 
reacthion chambers, functionalized surface for heterogeneous immunoassays were 
fabricated in three steps.  
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Figure 3.3.The basic fabrication steps to make the specific coating on the reaction 
chamber. 
 
In the first step thiolated streptavidin (SAv-SH) [49] from the Department of 
Biotechnology at the University of Turku was adsorbed on the surface by dispending 80 
µl of SAv-SH solution (1000 ng/40 µl) in the reaction chamber. The solution was 
incubated in a humid box at 36 °C overnight. SAv-SH surface was washed with 1 ml of 
1×DELFIA® washing solution (PerkinElmer-Wallac Oy, Turku, Finland) which 
contained 0.05 g/l of Tween20 detergent (Merk).  
 
The next step was to adsorb bovine serum albumin (BSA)-molecules on the surface to 
fill empty gaps left by the streptavidin to prevent unspecific binding onto the surface. 
This was done by dispending 80 µl of saturation solution (containing 50 mM Tris-HCl, 
pH 7, 150 mM NaCl 0.5 g/l NaN3, 60 g/l D-sorbitol and 2 g/l BSA) in the reaction 
chamber and incubating it overnight in the humid box at room temperature.  
 
In the last step the saturation solution was sucked out from the chamber and biotinylated 
antibodies (Bio-MAb Anti-TSH 5405) were attached to SAv-SH, via biotin-streptavidin 
linkage, by incubating 80 µl of antibody coating solution in the chamber at room 
temperature for 2 hours. Coating solution contained 200 ng/40 µl antibodies in 
Kaivogen buffer solution (Kaivogen Oy, Turku, Finland). Finally antibody coating 
solution was washed with 1 ml of 1×DELFIA® washing solution. 
3.1.4 Laser welding 
As the injection molding leaves microfluidic channels open they must be sealed 
properly before fluid handling. This was done by covering the cartridge with a black 
cover plate and welding these parts together with a laser (Figure 3.2). Laser welding 
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method is presented more accurately elsewhere [50]. Shortly, laser is used to heat the 
black cover plate through the transparent cartridge. Raise in the temperature mainly 
occurs on the interface between the plastics thus melting them together. Coated 
cartridges were stored at 4 °C in minicrip bags in a fridge before and after the welding 
process. 
 
Laser welding was done at the Department of Production Engineering (Tampere 
University of Technology). The used materials were commercial extruded PS-sheets, 
Vikureen (Athlone Extrusions, Ireland), NUDEC PS-sheet (NUDEC, Spain) or injection 
molded plates which had the same materials as cartridges. Black color additive (MB 
Deltaplast USS7940 Black) was included in the injection molding.    
3.2 Immunoassay measurements 
This section explains how immunoassays were performed and how data was obtained 
and processed for analysis. Material tests were carried out to study how different 
materials work as a substrate for the immunoassay. In these tests cartridges were 
fabricated from different materials and immunoassays were performed on them. The 
Chamber 2 was used in material tests. The Effect of different geometries and micro 
structures on immunoassay was studied using the same material in all the cartridges. 
The last experiment studied how moving the sample during incubation affect 
immunoassay. In this experiment, reciprocating flow of the sample was used during 
incubation. In the all immunoassay experiments, the same protocol was used to prepare 
samples. Differences in incubation and washing protocols are described separately for 
each chamber type. 
3.2.1 Sample preparation and assay steps 
In the sample preparation, TSH in the TSA-BSA buffer (50 mM Tris-HCl, pH 7.75, 154 
mM NaCl, 0.05% NaN3 and 7.5% BSA) was diluted with DI-water to form 
concentrations 7.5 mU/l, 15 mU/l and 30 mU/l. Final samples were made from these by 
mixing 5 µl TSH solution with 30 µl Kaivogen buffer solution and adding 5µl 
nanoparticle solution to the sample. Final nanoparticle concentration in the sample was 
108 particles in 40 µl. Nanoparticles were 107 nm polystyrene nanoparticles from 
Seradyn (Indianapolis, USA), which were doped with Europium(III)-chelates and 
coated with Anti-hTSH MAb-5409 at the Department of Biotechnology at the 
University of Turku, Finland. Zero-sample was made in the same way as the others but 
Kaivogen buffer was used instead of diluted TSH solution. In all experiments, three 
parallel samples were used for each sample concentration. 
 
With chambers 1 and 2, immunoassay was performed in the following way. The sample 
was manually pipetted inside the chamber and cartridge was incubated in an oven (FD 
53, BINDER GmbH) at 36 °C temperature. Immunoreaction was given 15 minutes to 
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occur and chamber was washed with 1 ml of 1×DELFIA® washing solution. Volume 
flow of 3.25 ml/min was used and washing was performed with the NE-4501 syringe 
pump (New Era Pump Systems, Inc., USA). 
 
With the Chamber 3, 16 µl sample was injected inside the chamber and incubated 15 
min. Wash included 133 µl washing solution which was pumped through the chamber 
with 433 µl/min flow rate. With these parameters, shear rate and washing time should 
correspond to those of the Chamber 2. 
 
Reciprocating flow of the sample was used with the Chamber 4. 16 µl sample was 
injected inside the channel. The syringe pump was programmed to suck the sample over 
the reaction area and to move sample back and forth over the reaction area. 10 µl of the 
sample was moved 5 seconds in one direction and then in other. After 15 minutes, the 
sample was sucked out from the chamber area and washed with 100 µl of washing 
solution. A 100 µl/min flow rate was used to wash the Chamber 4.  
3.2.2 Time resolved fluorescence measurement and data analysis 
Time resolved fluorescence measurements were done with a well plate reader, Victor2 
Multilabel counter (Wallac/PerkinElmer). The measurement of a single spot was 
performed by measuring photon count during 400 µs time interval after 400 µs of the 
excitation. Excitation filter 340 nm and emission filter 615 nm were used. The 
multilabel counter gives measurement data as photon counts per second (CPS). A 
custom made clamp adapter was used to position the cartridge to a correct place on the 
fluorescence reader. The measurement protocol for the chambers 1 and 2 was 
programmed to scan over the chamber using 10x10 matrix (Figure 3.4). The diameter of 
the excitation point is approximately 1.8 mm and the separation between the excitation 
points is 1 mm. For the chambers 3 and 4 the measurement protocol was changed to 
scan 5x5 matrix as the reaction area is much smaller in these chambers.  
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Figure 3.4. Fluorescence measurement was done by scanning 10x10 matrix around A) 
the Chamber 1 and B) the Camber 2. 5x5 scanning matrix was used for C) the Chamber 
3 and D) the Chamber 4. Orange circles represent measurement points which were 
used in analysis. 
 
Raw data from the multilabel counter was processed and analysed using Matlab®. The 
measurement data was obtained from measurement files and arranged to a matrix 
correspond the measurement protocol. The signal averages of 2x4 points from the center 
of the chamber were used in analysis for chambers 1 and 2 (Figure 3.4). These points 
were chosen as they are in the middle of the reaction chamber where points are fully 
inside the chamber area. For the thin chamber, measurement was done by scanning 5x5 
matrix over the reaction area. Only the center point was used in the analysis as it was 
the only point fully inside the reaction area.  
 
There was some displacement between individual cartridges even though the cartridge 
adapter was used. The matlab script was programmed to find the center of the chamber 
from the measured data in order to avoid taking wrong points to the analysis. 
Measurement points inside the chamber provide the highest signal values for the scan. 
The average signal value of the scan was used to find those points. The center of the 
chamber in the measurement matrix was calculated from those points and 2x4 matrix 
was positioned to the correct place. 
 
Average of three parallel samples was calculated separately for every concentration and 
used to draw a concentration curve for immunoassay. In next step average background 
signal (signal of the zero sample, ݏҧ଴) was reduced from all values and linear regression 
line was fitted to data so that fitted line will intercept with the origin. Measurement 
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sensitivity was defined as the slope of this linear regression line and was calculated with 
least square method as: 
 
ܵ݁݊ݏ݅ݐ݅ݒ݅ݐݕ = σ (௦ҧ೎ೖି௦ҧబ)௖ೖಿ೎ೖసభ
σ ௖ೖమ
ಿ೎
ೖసభ
        (3.1) 
 
Where ܰܿ is a number of concentrations used in an immunoassay. ܿ௞ is a concentration 
value and ݏҧ௖ೖ is a measured signal average corresponding the concentration. In most 
cases concentrations of samples were 0, 7.5, 15, 30 mU/L.  Standard deviation of the 
background signal, ߪ଴, was calculated from zero sample values with equation: 
 
ߪ଴ = ටଵேσ ൫ݏ଴௜ െ ݏҧ଴൯ଶே௜ୀଵ         (3.2) 
 
Where N is an amount of parallel samples per concentration c and ݏ௜ is a measurement 
result of an individual sample. The standard deviations of the different concentration 
samples are indicating how reliably immunoassay is working over the whole 
measurement range. The standard deviation of the zero sample was used to calculate the 
limit of detection value for the assay with the Equation 2.23. 
 
Percentage of covariance is parameter used to describe repeatability of immunoassays. 
This parameter is calculated as: 
 
ܥܸ% = ఙ೎
௦ҧ೎
× 100%         (3.3) 
 
Here, ߪ௖ is a standard deviation and ݏҧ௖ is an average signal value of parallel samples of 
a concentration ܿ. This parameter is used later in concentration curve plots as error bars. 
3.3 FEM-modeling of immunoassay 
A commercial FEM software COMSOL Multiphysics was used to develop 3D models 
for immunoassay reactions occurring inside the reaction chamber. The purpose was to 
study the effect of different geometries on the immunoassay and optimize the geometry 
for the cartridge.  
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Figure 3.5. Specific binding of the nanoparticle onto the surface. TSH molecule can 
bind A) to a nanoparticle or B) onto the surface. With help of TSH, the nanoparticle can 
bind to the surface C) through a TSH bound to the particle or D) through a TSH bound 
onto the surface. Overall, the nanoparticle binding on the surface is described with 
arrow E where all the reactions are combined. Modified with permission of Lasse 
Välimaa  
   
Immunoassay using nanoparticle labels contains complicated reactions (Figure 3.5). 
TSH molecules react not only with antibodies on the nanoparticle surface but also with 
the antibodies on the chamber surface. Through these bindings, a certain number of 
nanoparticles are able to bind to the surface with a certain reaction rate. Both the 
number of nanoparticles and the reaction rate depend on TSH concentration. Due to the 
lack of information about nanoparticles and the lack of software capabilities the models 
presented in this thesis are very simplified. Only the specific binding of the 
nanoparticles on the surface (Figure 3.5 E) is modeled. TSH binding reactions are left 
out. Next the different model cases are explained and the steps taken in model 
development are introduced. 
3.3.1 Model cases 
Immunoassay models are usually 2D models where the effect of walls is neglected. 
Thus, the Model 1 was a diffusion based model of the Chamber 1 (Figure 3.2 A) where 
the effect of the walls as the reacting surface was studied. Parameters affecting the 
reactions were studied with this model to see the effects. Model results were compared 
with experimental data and the most suitable parameters were used in the later models. 
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The Model 2 focused on the chamber height by using the geometry of the Chamber 2 
(Figure 3.2 B). The height of the geometry was parametrized and different heights were 
compared. Hypothesis was that the chamber height does not have significant effect on a 
diffusion based immunoassay. Reason for this can be found the Equation 2.15. If a 
sample is incubated for 15 minutes, it means that a nanoparticle having a diameter of 
107 nm is able to diffuse over a distance which is approximately 74 µm (Equations 2.14 
and 2.15). If the chamber height is larger than this, a result should not change 
significantly. Only the particles from 74 µm distance have enough time to react with the 
surface. On the other hand, with lower height immunoassay run out of particles and thus 
signal level should decrease.  
 
 
 Figure 3.2. Model boundary conditions on different geometries A) Chamber 1, B) 
Chamber 2 and C) Chamber 3. Green and blue areas are the reacting surface. Red ones 
are inlet and outlet for fluid flow. The surface concentration of bound nanoparticles on 
the green areas was calculated as a result. 
 
In the Model 3, fluid flow was added. The purpose was to study the reactions of the 
sample under a constant flow instead of a stationary incubation. Using a flowing 
sample, it is possible to increase the mass transfer to the surface and to help the system 
to reach equilibrium faster. The Model 3 used the Chamber 2 geometry and the 
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Chamber 3 was developed to maximize the mass transfer to a small reacting surface 
(Figure 3.2 C). 
3.3.2 Modeling steps 
A commercial CAD-software Solid Works was used to design geometries for mold 
fabrication. The same geometries were modified in such a way that only the necessary 
chamber geometry was imported to COMSOL.  Model parameters and equations are 
described next. Used physics were “transport of diluted species”, “surface reactions” 
and “laminar flow”. [47] 
 
Transport of diluted species physics 
 
This physic set is used for modeling the mass transportation of small concentrations 
inside the reaction chamber. As the purpose was to model how nanoparticles bind on the 
surface, the model needed only one concentration to represent them. Equations 
describing mass transfer are: 
 
׏ ή (െܦ௜׏ܿ௜) + ࢜ ή ׏ܿ௜ = ܴ௜        (3.4) 
 
ࡺ࢏ ൌ െܦ௜׏ܿ௜ + ࢜ܿ௜         (3.5) 
 
Here ܴ௜ stands for reaction rate and ࡺ࢏ is flux of specie i inside the system.ܿ௜ and ܦ௜ are 
the concentration and the diffusion coefficient of a substance i, respectively. ࢜ is the 
velocity field vector. [47] 
 
Domain conditions used were “convection and diffusion” and “initial values”. In first 
one ܦ௜ is defined by calculating value with equation 2.14. For nanoparticle which has a 
diameter of 107 nm, the diffusion coefficient is:  
 
ܦ௜ = ௞ಳ×ଷ଴ଽ.ଵହ௄଺గ×଻.଴ଶ଺଼×ଵ଴షర௉௔ή௦×ହ଼.ହ௡௠ = 6.023 × 10ି଼ ௖௠మ௦   
 
In the second domain the condition initial concentration of the nanoparticles is defined. 
As there is 108 nanoparticles in a sample of 40 µl concentration is then: 
 
ܿே௉ = ଵ଴ఴ௣௖௦ேಲ×ସ଴ஜ௟ = 4.151 × 10ିଵଶ ௠௢௟௟        (3.6) 
 
஺ܰ is the Avogadro number (6.022×10
23 pcs mol-1) which is used to transform the 
amount of substance to moles. Boundary conditions “no flux” and “flux” were used to 
describe walls and reacting surface. Flow based models included also “open boundary” 
boundary conditions for the inlet and the outlet.  
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“No flux” boundary was used in walls where there were no reactions occurring. 
Mathematically this boundary condition defines selected boundaries so that flux through 
the surface is zero: 
 
െ࢔ ή ࡺ࢏ = 0          (3.7) 
 
࢔ is the normal unit vector of the surface. “Flux” boundary condition was used to 
describe reaction rate ܴ௜ over the reacting surface. [47] Used reaction was simple 
monovalent binding reaction: 
 
ܰܲ + ܤܲ݇௔֎
݇ௗ
ܰܲܵ         (3.8) 
 
Here NP indicates the nanoparticles in bulk solution, BP is binding places on the surface 
and NPS is the nanoparticles bound on the surface. The reaction rate for nanoparticles, 
ܴே௉, through the surface is: 
 
ܴே௉ ൌ െ
ௗ[ே௉௦]
ௗ௧
ൌ െ݇௔[ܰܲ][ܤܲ] + ݇ௗ[ܰܲܵ]     (3.9) 
 
Square brackets mean the concentration of substance. The reaction rate is in this case 
negative as nanoparticles are reduced from bulk solution during the reaction. The 
number of the binding places and the initial concentration of the bound nanoparticles 
are defined in the “surface reactions” physics. Values for reaction rate constants were 
obtained from antibody data sheets. For antibodies on the surface (anti-TSH 5405) the 
values were 1.2×106 M-1s-1 and 1.9×10-4 s-1 for, respectively. For antibodies on the 
nanoparticles (anti-TSH 5409) the values for ka and kd were 2.1×106 M-1s-1 and 1.0×10-4 
s-1. Both values were tested, but the values of anti-TSH 5405 showed better 
correspondence to experimental data and were used in the rest of the models.  
 
“Open boundary” boundary condition defines that all incoming flow has a specific 
concentration, ܿ଴,௜. On the other hand, if a flow is going out from the system, material 
just disappears from the boundary:  
 
ܿ௜ = ܿ଴,௜if࢔ ή ࢜ < 0         (3.10) 
 
׏ ή (െܦ௜׏ܿ௜) = 0if࢔ ή ࢜ ൒ 0       (3.11) 
 
The velocity field ࢜ is neglected in the Models 1 and 2 as they are modeling stationary 
incubation. In flow based incubation model velocity field is first acquired by modeling 
fluid flow using “laminar flow” physics. [47] 
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Surface reactions 
 
This physic set describes reactions occurring on surfaces. The set includes equations in 
reactions and mass transfer (flux ࡺ௦,௜)  occurring on the surface. The reaction part 
includes both reactions occurring on between surface species ܴ௦,௜ and reactions between 
surface and bulk species, ܴ௕,௜. The number of surface species is also calculated as a 
fraction of filled binding places, ߠ௜. [47] 
 
డ௖ೞ,೔
డ௧
൅ ׏௧ ή ൫െܦ௦,௜׏௧ܿ௦,௜൯ = ܴ௦,௜       (3.12) 
 
ࡺ௦,௜ ൌ െܦ௦,௜׏௧ܿ௦,௜         (3.13) 
 
ߠ௜ = ௖ೞ,೔ఋ೔୻ೞ           (3.14) 
 
డ௖್,೔
డ௧
= ܴ௕,௜          (3.15) 
 
Here ܿ௦,௜ is the concentration of surface species, in this case bound nanoparticles. ߜ௜ is 
the site occupancy number describing how many binding sites bound nanoparticle 
would cover. Ȟ௦ is the number of binding places on the surface.  ܿ௕,௜ is the concentration 
of nanoparticles in the bulk solution. [47] 
 
It was assumed that particles are only able to bind on the surface and detach from it. It 
could be possible that particles are able to roll on the surface, but this kind of diffusion 
is very slow. Thus surface diffusion ܦ௦,௜ is assumed to be zero and the equations 3.12 
and 3.13 are neglected.  
 
Used boundary conditions were “surface properties”, “initial values” and “reactions”. 
“Reactions” boundary condition defines the reaction rate over the reacting surface the 
same way as in the transport of diluted species physics. In this case, the exception is that 
the reaction rate in equation 3.6 has an opposite sign. Nanoparticles are bound onto the 
surface and thus the number of bound nanoparticles is increasing. 
 
“Surface properties” boundary condition defines the number of binding places on the 
surface as a binding place density (BPD). In a real situation, on the surface there are 
many antibodies near to each other. As the nanoparticle is much bigger than a single 
antibody the nanoparticle will cover more than one antibody as it binds. As there is no 
absolute information about the surface density of antibodies and about the coverage, 
simplification is done for the BPD parameter. Instead of using antibodies, the surface is 
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described as binding places for nanoparticles. One nanoparticle will in this case occupy 
only one binding place.  
 
If nanoparticles form a triangularly closely-packed layer over the surface, they have a 
maximum density on the surface. For triangular closely packaged circles the coverage 
ratio is 0.9069. Therefore, for 107 nm diameter nanoparticles maximum BPD is: 
 
ܤܲܦே௉,௠௔௫ = ଴.ଽ଴଺ଽగ௥మήேಲ = 1.6748 ή 10ିଵ଴[௠௢௟௠మ ]      (3.16) 
 
The site occupancy number was set to 1 as it was assumed that a bound nanoparticle 
covers only one binding place. Lastly the surface diffusion was set to zero and from 
“initial values” boundary condition, the initial concentration of bound nanoparticles was 
set to zero. 
 
Laminar flow 
 
Laminar flow physics is used to model a fluid flow inside the channels and chambers. 
The flow field, ࢜, was gained from the physic as a result. The result was coupled to 
“convection and diffusion” domain condition (Equations 3.4 and 3.5) inside the 
transport of diluted species physics. Equations used in laminar flow physics are based 
on the Navier-Stokes equation and for an incompressible fluid they are presented in 
Comsol as: 
 
ߩ
డ࢜
డ௧
+ ߩ(࢜ ή ׏)࢜ ൌ ׏ ή [െ݌ࡵ ൅ Ɋ(׏࢜+ (׏࢜)்)] + ࡲ    (3.17) 
 
ߩ׏ ή ࢜ = 0          (3.18) 
 
ࡲ is a volume force caused by gravity. In these models it is neglected as volumes are 
very small and the gravitation does not have significant effect on the fluid flow. ࡵ is an 
identity matrix. [47] 
 
Boundary conditions used in flow models are “wall”, “inlet” and “outlet” boundaries. 
All walls were set to have a “no slip” condition, which means that the flow field on 
selected boundaries is zero: 
 
 ࢜ = 0           (3.19) 
 
The outlet was set to have “pressure, no viscous stress” condition so that the pressure, ݌, 
in the outlet was zero and viscous forces are vanishing at the boundary: 
 
݌ = ݌଴, [ߤ(׏࢜+ (׏࢜)்)]࢔ = 0       (3.20) 
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The inlet was set to have the “laminar inflow” condition with a certain flow rate
଴ܸ:  
 
ܮ௘௡௧௥׏௧ ή [െ݌ࡵ ൅ Ɋ(׏࢜+ (׏࢜)்)] ൌ െ݌௘௡௧௥࢔ǡ ׏௧ ή ࢜ = 0    (3.21) 
 
Entrance length ܮ௘௡௧௥ is used to model a channel which has the length of ܮ௘௡௧௥ and 
cross-section the same as the inlet does. From this solution the initial velocity field and 
entrance pressure, ݌௘௡௧௥, are calculated for the model. Default value of 1 m was used in 
the boundary condition as it should be long enough for the model to reach a laminar 
flow field. In flow based incubation models, 40 µl per 15 minute flow rate was used as 
it corresponds the sample volume and the incubation time. In reality, achieving this low 
flow rate is challenging with the syringe pump. Therefore flow based models are done 
to illustrate the effect of the flow on the immunoassay. [47]
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4 RESULTS AND DISCUSSION 
In this chapter all the results from the experiments are presented and discussed. Section 
4.1 discusses results from simulated models. Section 4.2 includes results from empirical 
experiments focusing on material and geometry comparisons.  
4.1 Immunoassay models 
In this section the results of different models are presented. Model 1 simulated the 
Chamber 1 and was used to study how different model parameters affect the surface 
concentration of the sample. Model 2 studied how the chamber height affects 
immunoassay. Model 3 studied the effect of a fluid flow on immunoassay.   
4.1.1 Evaluation of the immunoassay model 
The diffusion based model of the Chamber 1 was compared with data which contained a 
five-day incubation results obtained from the NanoFlow project. All curves were 
normalized to have the maximum value 1, because correlation between nanoparticle 
surface concentration and the amount of fluorescence is not known. As seen from 
Figure 4.1 a simulated curve is correlating quite well with the real experiments. The 
reaction rate constants of antibody 5405 seem to give a better fit for experimental data. 
Probably because TSH molecules are better attached to antibody 5409 and thus the 
slower antibody is limiting the binding reaction. 
 
As the nanoparticle may have a different reaction rate constants compared with a single 
antibody [37] simulation was driven using different ka and kd parameters (Equation 3.6). 
This was done to get a better fit for the concentration curve and to get better 
understanding of the system’s behavior. Parameters used were 1, 2, 3 and 5 multipliers 
for ka and the same values as dividers for kd. The second parameter studied was the 
number of binding places on the surface. Multipliers used for the binding place density 
were 0.8, 0.6, 0.4, 0.2 and 0.1. The effect of the reaction rate to the immunoassay is 
presented in Figure 4.2 and the effect of the binding place density in Figure 4.3. 
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Figure 4.1. Simulation results of the Model 1 compared with the five-day experiments. 
 
 
Figure 4.2. The Model 1 results: The effect of different reaction rate constants on the 
surface concentration. 
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It was noticed that the model gave identical results for those ka and kd values which had 
the same proportion ka/kd. When proportion increases the peak of the maximum 
concentration shifts to a later time point and vice versa. As data is normalized it should 
be mentioned that as the ka/kd ratio increases also the concentration of bound 
nanoparticles increases.  
 
 Figure 4.3. The Model 1 results: The effect of the binding place density on the surface 
concentration. 
 
With a lower binding place density value the peak shifts to an earlier time point. In the 
end, there was no clear decrease on the scaled surface concentration. Reason for this 
might be the fact that when there is a small amount of binding places, the surface is 
saturated faster than with a higher binding place amount. Thus the maximum signal 
value is also reached faster. On the other hand as the surface gets saturated particles are 
able to spread faster into corners. Therefore the signal does not drop after the maximum 
surface concentration as much as with the higher BPD. One has to remember that the 
curves are scaled and in the real case a surface with less binding places would also 
produce less signal than a surface with a higher BPD. Because later models are used to 
simulate only 2 h incubation, it seemed reasonable to use the original values of anti-
TSH 5405 antibody which gave the best fit for experimental results within 10 h. 
 
As mentioned earlier with diffusion models it is important to take into account the effect 
of the walls. When comparing simulations where walls are neglected to simulations 
where they are included as reacting surface the difference is quite significant (Figure 
4.1). Reason for the difference is a concentration gradient which is formed 
perpendicular to all reacting surfaces (Figure 4.4). When walls act as a reacting surface, 
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mass transfer to corners is decreased. Bindings occur first to middle parts of the walls 
and the bottom. As nanoparticles may detach from the surface they will slowly spread 
towards the corners. This is the most probable reason for the signal to lower after 10 h 
incubation. In the end reactions reach equilibrium everywhere and surface concentration 
reaches the same value also in the corners. The whole system is in equilibrium and thus 
concentration all around the chamber reaches constant value.    
 
Figure 4.4. A) Cross-section of the Chamber 1 from time point 15 min shows that a 
concentration gradient is formed in the U-shape along the walls. B) Concentration 
measured along the centerline of the chamber shows the spreading of the diffusion layer 
during the incubation. 
 
Without walls, a concentration gradient is formed only to the bottom. Thus also corners 
nearly get the same amount of particles as the center part of the bottom. From these 
results, it would be reasonable to assume that walls are disturbing the process to reach 
equilibrium. To take into account this an optimal reaction chamber should be as flat as 
possible in order to minimize the effect of the walls.  
4.1.2 Chamber height studies 
The geometry of the Chamber 2 was used to study the effect of the chamber height. The 
Model 2 was the same as the Model 1 but instead of using the Chamber 1 the Chamber 
2 was used. As the Chamber 2 was flat, it was more suitable to parameterize the 
chamber height. Results of the simulations can be seen in Figure 4.5. 
 
When the chamber height decreases the maximum number of particles on the surface 
will also decrease. This is caused by a limited sample volume inside the chamber. The 
number of nanoparticles is simply running out with a lower chamber, because of the 
increasing surface to volume ratio. It was estimated that during 15 minutes a 
nanoparticle is able to diffuse over 74 µm distance at the maximum. This seems to be 
correlating quite well with the model as 75 µm high chamber reaches equilibrium 
already after 30 minutes. The reason for the longer time might be that the diffusion layer 
A      B  
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is increasing all the time and the concentration gradient is getting lower. As the model 
uses gradients to calculate fluxes it means that the flux through the chamber is 
decreasing over the time. An analytical model (Equation 2.14) does not take this in to 
account and thus the model result differs from it. 
 
From Figure 4.5, one can see that curve starting points differ from each other. This is 
caused by numerical errors during simulations. This is the most probably caused by 
rounding errors as concentration values are so small. This happens in all the cases but it 
does not affect results significantly. 
 
 
Figure 4.5. The Model 2 results. The Chamber 2 geometry was used with different 
heights. The result from the Chamber 1 is shown as a reference. 
 
15 minute incubation time was used in experiments. According to these simulation 
results 150-200 µm height would be the best for the chamber. A smaller chamber will 
run out of nanoparticles and thus have lower signal values. On the other hand a chamber 
higher than 200 µm will have some extra sample volume which is never used in the 
reaction. 
4.1.3 Flow based incubation studies 
The purpose of a flowing sample was to prevent the formation of the concentration 
gradient and especially to prevent the gradient from spreading and thus to decrease the 
mass transfer towards the surface. When there is a flow through a chamber new 
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particles are coming over the surface all the time and thus more bindings will occur. 
This was simulated by using the same geometries as in the second model but coupling 
the fluid flow to the Model 3. From the results (Figure 4.6) it is clearly seen that with a 
constant flow rate binding is related to the chamber height. As the chamber height gets 
lower the flow velocity gets higher. The higher the flow velocity is thinner the diffusion 
layer gets and providing higher mass transfer. This means that reactions occur faster. 
 
 
Figure 4.6. The Model 3 results. When a flow is applied to the immunoassay, the 
surface concentration is increasing as the chamber height is decreasing. Height is 
marked inside parentheses. Flow rate 40 µl in 15 min was used in the model. 
 
After these simulations it was clear that there would be no sense to have a diffusion 
limited system. The Chamber 3 geometry was designed so that the reaction area would 
be as small as possible. The bottom was decreased to a rectangular area of 2x2 mm. 
Reason for this was that Victor multi-label counter had an excitation spot which is an 
approximately circular area with a diameter of 1.8 mm. Theoretically, measurement 
could be conducted using a single measurement point without scanning a large area 
around the chamber. The height of the chamber was 150 µm as it was still providing 
enough particles to make wet lab experiments using stationary and flowing sample 
incubations for a comparison. One reason for choosing this height was also the fact that 
producing smaller features using injection molding would be challenging.  
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4.2 Immunoassay experiments 
This section describes the results of immunoassay experiments. In Section 4.2.1 results 
of the material experiments using the Chamber 2 are presented. The purpose was to 
study the effect of the material on the immunoassay performance and find the most 
suitable material for the cartridge. Section 4.2.2 presents the results of the geometry 
comparison between chambers 1 and 2. Section 4.2.3 presents the immunoassay results 
of the Chamber 3. The effect of the micro structures on the immunoassay is also 
presented in this section. The last section 4.2.4 presents results of the Chamber 4 where 
the immunoassay was performed using a reciprocating flow. 
4.2.1 Different polystyrene grades 
The immunoassay performance on different polystyrene grades and PMMA was studied 
using the Chamber 2. Results of the experiments are presented in Figure 4.7 and Figure 
4.8. In Figure 4.7, different plastic grades are presented with their own color. In the 
legend, the material of injection molded channels is written before a slash and the 
material of the cover plate is written after the slash.  
 
From the signal averages it is clearly seen that polystyrene grade Empera 124N was 
giving the highest signal levels. The difference between PS 158K and Styrolux was not 
significant. PMMA gave the lowest signal values. PMMA probably has a poor 
transmittance for the excitation wavelength.  
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Figure 4.7. Results of the material experiments. Average of three parallel samples was 
used. 
 
Figure 4.8 presents a background signal level average (Bgr), standard deviation of the 
background signal (Bgr-ı, Equation 3.2), measurement sensitivity (Equation 3.1) and 
the limit of detection (Equation 2.23) for each experiment. The results are scaled in y-
axis to fit in the figure. Scaling of the value is informed after the unit in the x-axis. 
Examination of this figure reveals that there was no significant difference in the 
background levels between the polystyrene grades. A comparison test gave very low 
background values for both PS 158K and Styrolux grade, but the reason for this was not 
tracked down. Background levels are affected by the coating and its properties to 
prevent unspecific binding. Also the concentration of nanoparticles affect as there 
would be more particles to bind on surface as their concentration increases. Because all 
the samples are done similarly there might have been some problem with the coating 
and the surface might have had less antibodies. 
 
Deviations of background signals are in most cases lower with laser welded cartridges. 
Channel cross-section varies with taped cartridges as taping is done manually. This may 
explain larger deviation for those cartridges. Also the tape material may have some 
negative effect on deviations. For Empera, there was also a high deviation value in one 
experiment. This can be explained by problems with bubbles during the washing step.  
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 Figure 4.8. Background, background deviation, sensitivity and limit of detection values 
of the material tests. Units and scaling of the data is shown on X-axis. 
 
The Figure 4.8 does not have space for the error bars. As zero samples had lowest 
average signal values, their percentages of covariance were mostly around 20%. For 
other samples these values were around 14%.   
 
As background values are nearly on the same level in each polystyrene case, it is quite 
obvious that sensitivity is the best with those materials which also has a high signal 
level. Sensitivities of Empera were 92.4×103, 59.3×103 and 44.4×103 CPS mU-1 L-1 as 
other grades reached a maximum of 36.5×103 CPS mU-1 L-1. 
 
Limit of detection values are in most cases around 1 mU/L. For taped cartridges and one 
Empera batch, LOD values are much higher due to high background deviation. The best 
LOD result, 0.23 mU/L, was obtained with Styrolux 656C, but in that experiment the 
background deviation was exceptionally low, only 2030 CPS. If the deviation would 
have been on the same scale with the others, the LOD would not differ very much. On 
the contrary as the deviation of Empera is around the same level with the others or 
more, it is more probable that it actually has the best LOD value, 0.30 mU/L.  
 
Although Empera seemed to be the best material for the immunoassay there were 
problems in producing intact cartridges from it by injection molding. The same problem 
occurred with PS 158K grade. These two were very brittle plastics and thus they tended 
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to crack when ejected from the mold. The rest of the experiments were carried on with 
Styrolux 656C grade as it was a more durable material for injection molding. 
4.2.2 Reaction chamber geometry 
Comparison of reaction chambers 1 and 2 were carried on with cartridges made of 
Styrolux 656C. Experiments were done separately and thus the tests done using the 
Chamber 1 miss the results having a concentration 7.5 mU/L. When comparing the 
results in Figure 4.9 it can be seen that the concentration curves are quite similar and 
there are only slight differences in signal levels. As nanoparticles are able to diffuse 74 
µm distance during incubation the whole chamber volume is not exploited. Only a small 
number of particles are able to react with the surface in both geometries and thus the 
concentration curves are so similar. 
 
 
Figure 4.9. Concentration curves of immunoassays done in chambers 1 and 2. 
 
The background level was slightly smaller in the Chamber 2, 102×103 CPS, compared 
with the Chamber 1, 137×103 CPS (Figure 4.10). Background deviations were not 
comparable as the results for the Chamber 2 were the same as those which had 
exceptional low values in the material comparison. The background deviation of the 
Chamber 1 was 38.7×103 CPS and as for the Chamber 2 it was 2.0×103 CPS. This result 
indicates that the number of the parallel samples should have been much larger than 
three. 
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Figure 4.10. Background levels, background deviation, sensitivity and limit of detection 
values of the chambers 1 and 2. 
 
Sensitivities were 30.7×103 CPS mU-1 L-1 for the Chamber 1 and 26.2×103 CPS mU-1 L-
1 for the Chamber 2. LOD values were 3.79 mU/L for the Chamber 1 and 0.23 mU/L for 
the Chamber 2. One reason why the Chamber 1’s deviation values are high is that 
washing is less effective than in the Chamber 2’s case. As for the Chamber 2, washing 
solution go through the chamber in more laminar manner compared with the Chamber 
1. The Chamber 1 inlets are very small and they are not at the same level as the reacting 
surface. As the chamber has a cup like structure it is possible that most of the washing 
solution is just flowing through the chamber without flushing the surface properly. 
Another problem is the large difference in size between the chamber and the inlet 
channel which may in some cases cause bubbles inside the chamber when the sample is 
sucked out. These bubbles will definitely disturb proper washing and cause the higher 
standard deviation for the zero sample.  
4.2.3 Immunoassay on microstructures 
The nanoparticle batch was changed before doing the experiments using the Chamber 3 
geometry. Thus the results given by this geometry are not fully comparable with those 
of the earlier geometries. 
 
The effect of the surface roughness was studied using the Chamber 3 geometry where 
two of the channels had different laser ablated surfaces. One chamber had an array of 
single hemispherical structures (Figure 4.11 A and C) and other chamber had an array 
of four hemispherical structures grouped together (Figure 4.11 B and D). The third 
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surface was a smooth polished surface which was used as a reference. Holes in the mold 
were 5 µm deep, but replicated structures were only 2.6 µm high. As plastic was 
transparent it was not possible to measure the surface roughness with an optical 
profilometer. Although replication was not perfect it was decided to test immunoassay 
on these surfaces. From profilometer pictures it was assumed that the surface consisting 
of the grouped structures would have a larger total area and thus it should give higher 
signal values. 
 
 
Figure 4.11. Profilometer and SEM pictures of the micro structured surfaces. A and C: 
Array of single structures and B and D: the array of lumped structures. SEM pictures 
are courtesy of Jarkko Mutanen.  
 
Figure 4.12 shows that both micro structured surfaces gave higher signal values 
compared with the smooth polished one. Surprisingly, the single structured surface gave 
much higher signal values compared with the grouped structures. Sensitivities were 
2.91×103 CPS  mU-1 L-1, 5.08×103 CPS  mU-1 L-1 and 10.94×103 CPS mU-1 L-1 for 
smooth, grouped structures and single structures, respectively.  
 
     A         B  
 
 
 
 
 
 
 
 
 
C      D   
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 Figure 4.12. Signal average plots of thin chamber experiments show that micro 
structures have a significant effect on immunoassay results. 
 
Unfortunately, as the surface area is increases it seems that the possibility for unspecific 
binding increases as well. This can be seen from the background levels which were 
clearly higher for the chambers containing microstructures compared with the chamber 
which did not. Background values were 14.9×103 CPS, 27.7×103 CPS, 23.5×103 CPS 
for smooth, grouped structures and single structures, respectively. 
 
Figure 4.13 shows that standard deviations of background averages were also higher 
with micro structured surfaces. Values were 2.7×103 CPS, 7.2×103 CPS, 7.1×103 CPS 
for smooth, grouped structures and single structures, respectively. Limit of detection 
values were 2.78 mU/L, 4.27 mU/L and 1.95 mU/L for smooth, grouped structures and 
single structures, respectively. 
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Figure 4.13. Background levels, background deviation, sensitivity and limit of detection 
of the Chamber 3. 
 
Low signal values of the Chamber 3 compared with the chambers 1 and 2 can be 
explained with the new nanoparticle batch which was known to have a lower label 
amount than the earlier batch. Assuming that there was the same number of 
nanoparticles on the polished surface of the Chamber 3 as there was in the Chamber 1, it 
would be possible to use scaling to compare the results. Background level was 14.9×103 
CPS for the smooth chamber and 137×103 CPS for the Chamber 1. The Chamber 1 has 
nearly a tenfold higher background level. If sensitivities, 2.91×103 CPS mU-1 L-1 for the 
Chamber 3 and 30.7×103 CPS mU-1 L-1 for the Chamber 1, are compared they seem to 
be quite similar with tenfold scaling.  
 
The main problem with the Chamber 3 was the capillary effect which caused bubbles to 
occur inside the chamber during washing. These bubbles prevented proper washing and 
thus background deviations were high. This again caused large limit of detection values. 
Because of these problems the Chamber 4 geometry was designed and reciprocating 
flow during sample incubation was tested with it. 
4.2.4 Immunoassay using reciprocating flow 
In the last experiment, the sample was moved over the reaction area in the Chamber 4. 
This was compared with the Chamber 2 where the sample was incubated stationary. 
There were quite many problems. The laser welding of these chambers failed and thus 
the test was carried on using cartridges which were taped with adhesive tape. Failure of 
the welding might have been caused by a small scratch in the mold which prevented a 
proper contact with the cover plate. This caused a poor welding seam which leaked. The 
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second reason could be that the material was changed. Styrolux 656C was out of stock 
and thus KR-01 (from K-resin), which should be similar material was used in this 
experiment. KR-01 probably has slightly different melting properties and was thus 
welded poorly.  
 
There were also some technical problems with the syringe pump and connections with 
cartridge inlets during reciprocating incubation and thus the data from the concentration 
15 mU/L was lost. In the rest of the moving experiments, it was noted that fluid did not 
move as it was supposed to. The pump was programmed to move 10 µl volume of the 
sample back and forth, but the movement was much less in all cases. 
 
Figure 4.14. Signal averages from the Chamber 4 with reciprocating flow of the sample 
compared with stationary incubation in the Chamber 2. 
 
Even though the experiment was not perfect, it showed that the Chamber 4 having a 
reciprocating flow gave higher signal values than the Chamber 2 where the sample was 
incubated stationary (Figure 4.14). It was assumed that as there are more particles 
coming towards the surface when the sample is moving the number of bound 
nanoparticles increases. Thus sensitivity should increase too as it seems to happen. 
Sensitivities were 16.4×103 CPS mU-1 L-1 and 11.3×103 CPS mU-1 L-1 for the Chamber 
4 and the Chamber 2, respectively.  
 
The background level is over two times higher with reciprocating movement, 51.8×103 
CPS, compared with stationary incubation, 21.1×103 CPS (Figure 4.15).  It may be 
possible that as the flow is increases the specific binding it also increases the unspecific 
binding. 
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Figure 4.15. Background levels, background deviation, sensitivity and limit of detection 
of comparison of the stationary and the reciprocating incubation experiment. 
 
Limit of detection values were 1.99 mU/L and 0.52 mU/L for the Chamber 4 and for the 
Chamber 2, respectively (Figure 4.15). The deviation of the background signal is again 
really small with the Chamber 4, 2.8×103 CPS, compared with the Chamber 2, 7.5×103 
CPS. Thus the limit of detection value is lower for the Chamber 4 than for the Chamber 
2.  
 
This rises up the question about the reliability of the results. The Chamber 4 is sleeker 
than the Chamber 2 and it should provide a better wash for the reacting surface. This 
can explain the smaller background deviation, but more experiments are needed to 
confirm that the deviation is not small just by a change. There are only three parallel 
samples used in the experiments and thus deviation values may be erroneous. To 
achieve more reliable results the number of parallel samples should be increased. 
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5 CONCLUSION 
This thesis presented how a finite element method modeling can assist in designing new 
geometries for microfluidic immunoassays. The model itself was very simplified but it 
still offered new knowledge about phenomenon occurring inside the reaction chamber. 
Especially the knowledge on how diffusion is limiting the reactions inside the chamber 
is now understood much better than before.  
 
FEM-models demonstrated how the mass transfer towards the reaction surface can be 
increased with a flowing sample. When the chamber size is minimized, the mass 
transfer can be further increased. The reacting surface outside the measurement area is 
excess and useless area which is stealing part of an analyte and labels. By minimizing 
this area, all substances could be used inside the measurement area in order to reach the 
reaction equilibrium state faster. When the equilibrium is reached, the deviation 
between parallel samples should also decrease. 
 
Experiments showed that the material of the cartridge has a huge effect on 
immunoassay performance. Even different polystyrene grades had an effect on signal 
levels and sensitivities. In most cases, limit of detection values were around 1 mU/L. A 
challenge in the material was that even though Empera 124N grade was chemically the 
most suitable for immunoassay cartridges, it was not as good material for injection 
moulding the chamber geometries as the others. Cartridges made from this material 
were cracking as they were ejected from an injection moulding device. This can be 
partially avoided by designing the geometries more carefully and by taking into account 
the injection moulding process itself.  
 
Other significant result from the experiments was that micro structures increased 
immunoassay sensitivity nearly 3-fold compared with a smooth surface. The 
reciprocating flow of the sample in a thin chamber gave 1.4-fold higher sensitivity and 
the limit of detection was 3.8 times better compared to the stationary incubation in a 
larger chamber. Combining a micro structured chamber with the moving sample would 
be an interesting choice for a final cartridge.  
 
Based on the results of the thesis the reaction chamber should have the following 
characteristics: Small reaction area compared to the volume of the fluid, micro 
structures on the reacting surface and low a small chamber height. In addition, the 
reciprocating flow of the sample should be used. 
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There are several topics to focus on in the future. By focusing on how to prevent 
unspecific binding it would be possible to decrease background level and its deviation. 
By doing this the limit of detection should decrease further. The Chamber 3 geometry 
was modified to the Chamber 4 where washing does not generate bubbles as easy as 
before. Changing the stationary incubation to a moving sample has shown to be 
challenging. To achieve a reliable reciprocating movement, it would be possible to use 
pressure control instead of the syringe pump. Washing protocol should be tested with 
the Chamber 4 to enhance the washing procedure. At least different flow rates and 
solution volumes should be tested in order to reach a low background level and standard 
deviation. For more reliable results, more parallel samples should be used.  
 
Models used in the thesis were really simplified. They did not take into account the 
unspecific binding of nanoparticles or concentration of the analyte. Adding the effect of 
analyte concentration would be big challenge to make model more accurate. 
Nanoparticles are much more complicated to model than single antibodies and thus 
more knowledge about them is needed. Single antibodies are smaller than nanoparticles 
and thus they have a higher diffusion coefficient. This would be an option for 
nanoparticles even though the signal level would decrease. In addition to this the model 
can be quite easily transformed to use single antibodies as labels. Also a two-phase 
simulation of reciprocating incubation would be useful in order to more accurately 
observe how concentration change inside the sample plug. Preliminary tests have shown 
that a two-phase modeling is much more challenging in comparison with single-phase 
flows which were used in the thesis. 
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